Device for reuse of pap therapy

The respiratory therapy system with a supplemental flow device and sensory monitoring improves patient comfort and compliance by delivering air flow away from the airway and managing data efficiently, addressing the limitations of existing therapies and diagnostics.

CN119075101APending Publication Date: 2024-12-06RESMED PTY LTD
View PDF 23 Cites 0 Cited by

Patent Information

Application Number
CN202410678114.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-29
Filing Date
2024-05-29
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing respiratory therapies for breathing disorders suffer from discomfort, inefficiency, high cost, and lack of compliance due to inadequate patient interfaces and noisy ventilation systems, as well as the need for cumbersome data management and expensive diagnostic methods like polysomnography.

Method used

A respiratory therapy system with a patient interface that includes a supplemental flow device to deliver air flow away from the airway, stimulating responses and altering the environment, combined with a flow regulator valve and sensory monitoring for improved comfort and compliance, and a system for efficient data management.

Benefits of technology

Enhances patient comfort and compliance by reducing noise and improving interface fit, while providing effective therapy and streamlined data management, thus addressing the inefficiencies of existing systems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119075101A_ABST
    Figure CN119075101A_ABST
Patent Text Reader

Abstract

An apparatus for delivering pressurized air or breathable gas to a patient is disclosed. The apparatus may include a flow generator configured to generate a flow of air. The patient interface may be constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airway. The patient interface may be configured to deliver pressurized air or breathable gas to an airway of a patient for respiratory therapy. An air delivery tube may be coupled between the flow generator and the patient interface to deliver a flow of air from the flow generator as pressurized air or breathable gas to the patient interface. The supplemental flow device may be configured to deflect at least a portion of the pressurized air or breathable gas away from the airway of the patient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present technology relates to one or more of screening, diagnosis, monitoring, treatment, prevention and alleviation of breathing-related disorders. The present technology also relates to medical devices or equipment and their uses. Background Art

[0002] The human respiratory system and its disorders

[0003] The human respiratory system facilitates gas exchange. The nose and mouth form the entrance to the patient's airway.

[0004] The airway includes a series of branching tubes, which become narrower, shorter and more numerous as the branching tubes penetrate deeper into the lungs. The main function of the lungs is gas exchange, allowing oxygen to move from the inhaled air to the venous blood, and carbon dioxide to move in the opposite direction. The trachea is divided into the right main bronchus and the left main bronchus, which are eventually further divided into terminal bronchioles. The bronchi constitute the conducting airways and do not participate in gas exchange. Further branches of the airway lead to respiratory bronchioles and eventually to alveoli. The alveolar region of the lungs is where gas exchange occurs and is referred to as the respiratory region. See John B. West, published by Lippincott Williams & Wilkins in 2012, Respiratory Physiology, 9th edition.

[0005] There is a range of breathing disorders. Some disorders can be characterized by specific events such as apnea, hypopnea and hyperpnea.

[0006] Examples of breathing disorders include obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory insufficiency, obesity hypoventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), and chest wall disorders.

[0007] Obstructive sleep apnea (OSA) is a form of sleep-disordered breathing (SDB), characterized by events including occlusion or obstruction of the upper airway during sleep. It results from a combination of an abnormally small upper airway and normal loss of muscle tone in the area of ​​the tongue, soft palate, and posterior oropharyngeal wall during sleep. The condition causes the affected patient to stop breathing, typically for periods of 30 to 120 seconds, sometimes 200 to 300 times per night. This often causes excessive daytime sleepiness and may cause cardiovascular disease and brain damage. The syndrome is a common disorder, especially common in middle-aged overweight men, but the affected person may not be aware of this problem, for example, see U.S. Patent No. 4,944,310 (Sullivan).

[0008] Cheyne-Stokes respiration (CSR) is another form of sleep-disordered breathing. CSR is a disorder of the patient's respiratory controller in which there are rhythmic alternating cycles of boom-and-bust ventilation called CSR cycles. CSR is characterized by repeated hypoxia and reoxygenation of arterial blood. CSR can be harmful due to repeated hypoxia. In some patients, CSR is associated with repeated micro-awakenings from sleep, which cause severe sleep disruption, increased sympathetic nerve activity, and increased afterload, see, e.g., U.S. Patent No. 6,532,959 (Berthon-Jones).

[0009] Respiratory failure is an umbrella term for breathing disorders in which the lungs cannot take in enough oxygen or exhale enough CO2 to meet the patient's needs. Respiratory failure can encompass some or all of the following disorders.

[0010] Patients with respiratory insufficiency (a form of respiratory failure) may experience abnormal shortness of breath during exercise.

[0011] Obesity hypoventilation syndrome (OHS) is defined as the combination of severe obesity and chronic hypercapnia during wakefulness in the absence of other known causes of hypoventilation. Symptoms include dyspnea, morning headache, and excessive daytime sleepiness.

[0012] Chronic obstructive pulmonary disease (COPD) encompasses any of a group of lower airway diseases that have certain common features. These include increased resistance to air flow, prolonged expiratory phase of breathing, and loss of normal elasticity of the lungs. Examples of COPD are emphysema and chronic bronchitis. COPD is caused by chronic smoking (a major risk factor), occupational exposure, air pollution, and genetic factors. Symptoms include: dyspnea on exertion, chronic cough, and sputum production.

[0013] Neuromuscular disease (NMD) is a broad term that encompasses many diseases and ailments that damage muscle function directly through intrinsic muscle pathology or indirectly through neuropathology. Some NMD patients are characterized by progressive muscle damage, which leads to loss of walking ability, wheelchair use, dysphagia, respiratory muscle weakness, and ultimately death from respiratory failure. Neuromuscular disorders can be divided into rapidly progressive and slowly progressive: (i) rapidly progressive disorders: characterized by muscle damage that worsens over months and leads to death within a few years (e.g., amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD) in adolescents; (ii) variable or slowly progressive disorders: characterized by muscle damage that worsens over years and only slightly shortens life expectancy (e.g., limb-girdle type, facioscapulohumeral type, and myotonic muscular dystrophy). Symptoms of respiratory failure in NMD include: increasing general weakness, dysphagia, dyspnea during exercise and rest, fatigue, drowsiness, morning headache, and difficulty concentrating and mood changes.

[0014] Chest wall disorders are a group of thoracic deformities that result in inefficient connections between the respiratory muscles and the thorax. These disorders are usually characterized by restrictive defects and have the potential for long-term hypercapnic respiratory failure. Scoliosis and / or kyphoscoliosis can cause severe respiratory failure. Symptoms of respiratory failure include: dyspnea on exertion, peripheral edema, orthopnea, recurrent chest infections, morning headaches, fatigue, poor sleep quality, and loss of appetite.

[0015] A range of therapies have been used to treat or alleviate such conditions. In addition, such therapies can be used to prevent breathing disorders in otherwise healthy individuals. However, these therapies have a number of disadvantages.

[0016] therapy

[0017] Various respiratory therapies, such as continuous positive airway pressure (CPAP) therapy, non-invasive ventilation (NIV), invasive ventilation (IV), and high flow therapy (HFT) have been used to treat one or more of the above-mentioned respiratory disorders.

[0018] Respiratory pressure therapy

[0019] Respiratory pressure therapy is the application of air supplied to the entrance of the airway at a controlled target pressure that is nominally positive relative to atmosphere throughout the patient's respiratory cycle (as opposed to negative pressure therapy such as a tank or breastplate ventilator).

[0020] Continuous positive airway pressure (CPAP) therapy has been used to treat obstructive sleep apnea (OSA). The mechanism of action is that the continuous positive airway pressure acts as a pneumatic splint and can prevent upper airway occlusion, such as by pushing the soft palate and tongue forward and away from the posterior oropharyngeal wall. Treatment of OSA by CPAP therapy can be voluntary, and therefore patients may choose not to comply with therapy if they find the device used to provide such therapy to be uncomfortable, difficult to use, expensive, and unsightly.

[0021] Non-invasive ventilation (NIV) provides ventilation support to the patient through the upper airway to help the patient breathe and / or maintain adequate oxygen levels in the body by completing some or all of the work of breathing. Ventilatory support is provided via a non-invasive patient interface. NIV has been used to treat CSR and respiratory failure in the form of OHS, COPD, NMD and chest wall disorders. In some forms, the comfort and effectiveness of these therapies can be improved.

[0022] Invasive ventilation (IV) provides ventilation support to patients who are no longer able to breathe effectively and can be provided using a tracheostomy tube or an endotracheal tube. In some forms, the comfort and effectiveness of these therapies can be improved.

[0023] Flow therapy

[0024] Not all respiratory therapies are intended to deliver prescribed treatment pressures. Some respiratory therapies are intended to deliver prescribed respiratory volumes by delivering an inspiratory flow curve (possibly superimposed on a positive baseline pressure) within a target duration. In other cases, the interface to the patient's airway is "open" (unsealed), and respiratory therapy can only supplement the patient's own spontaneous breathing with a flow of regulated or enriched gas. In one example, high flow therapy (HFT) can be to provide a continuous, heated, humidified air flow to the entrance of the airway through an unsealed or open patient interface with a "treatment flow" that remains roughly constant throughout the respiratory cycle. The treatment flow is nominally set to exceed the patient's peak inspiratory flow. HFT has been used to treat OSA, CSR, respiratory failure, COPD and other respiratory disorders. A mechanism of action is that the high flow air at the airway entrance improves ventilation efficiency by flushing out or flushing the exhaled CO2 from the patient's anatomical dead zone. Therefore, HFT is sometimes referred to as dead zone therapy (DST). Other benefits can include the possibility of increased warmth and humidity (possibly beneficial in secretion management) and appropriate increased airway pressure. As an alternative to a constant flow, the therapy flow may follow a curve that varies during the respiratory cycle.

[0025] Another form of flow therapy is long-term oxygen therapy (LTOT) or supplemental oxygen therapy. A physician may prescribe a continuous flow of oxygen-enriched air delivered to a patient's airway at a specific oxygen concentration (from 21% to 100% of the oxygen fraction in ambient air) at a specific flow rate (e.g., 1 liter per minute (LPM), 2 LPM, 3 LPM, etc.).

[0026] Supplemental oxygen

[0027] For some patients, oxygen therapy can be combined with respiratory pressure therapy or HFT by adding supplemental oxygen to the pressurized air flow. When oxygen is added to respiratory pressure therapy, this is called RPT with supplemental oxygen. When oxygen is added to HFT, the resulting therapy is called HFT with supplemental oxygen.

[0028] Respiratory therapy systems

[0029] These respiratory therapies can be provided by a respiratory therapy system or device.Such systems and devices can also be used to screen, diagnose, or monitor conditions without treating them.

[0030] A respiratory therapy system may include a respiratory pressure therapy device (RPT device), an air circuit, a humidifier, a patient interface, an oxygen source, and data management.

[0031] Another form of therapy system is a mandibular repositioning device.

[0032] Patient Interface

[0033] The patient interface can be used to engage the respiratory equipment to its wearer, for example by providing an air flow to the entrance of the airway. The air flow can be provided to the patient's nose and / or mouth via a mask, to the patient's mouth via a tube, or to the patient's trachea via a tracheostomy tube. Depending on the therapy applied, the patient interface can, for example, form a seal with an area of ​​the patient's face to facilitate delivery of gas at a pressure sufficiently different from the ambient pressure (for example, at a positive pressure of about 10 cmH2O relative to the ambient pressure) to achieve therapy. For other forms of therapy, such as delivering oxygen, the patient interface may not include a seal sufficient to facilitate delivery of the gas supply to the airway at a positive pressure of about 10 cmH2O. For flow therapies such as nasal HFT, the patient interface is configured to blow air into the nostrils, but specifically avoids complete sealing. An example of such a patient interface is a nasal cannula.

[0034] Sealing structure

[0035] The patient interface may include a seal-forming structure. Since the seal-forming structure is in direct contact with the patient's face, the shape and configuration of the seal-forming structure may directly affect the effectiveness and comfort of the patient interface.

[0036] The patient interface can be characterized in part according to the design intent of where the seal-forming structure will engage with the face during use. In one form of the patient interface, the seal-forming structure may include a first sub-portion that forms a seal around the left nostril and a second sub-portion that forms a seal around the right nostril. In one form of the patient interface, the seal-forming structure may include a single element that surrounds both nostrils during use. Such a single element may be designed, for example, to cover the upper lip area and the bridge of the nose area of ​​the face. In one form of the patient interface, the seal-forming structure may include an element that surrounds the mouth area during use, for example, by forming a seal on the lower lip area of ​​the face. In one form of the patient interface, the seal-forming structure may include a single element that surrounds both nostrils and the mouth area during use. These different types of patient interfaces may be named by their manufacturers under various names, including nasal masks, full-face masks, nasal pillows, nasal flutters, and oronasal masks.

[0037] For example, due to the different shapes, structures, variability, and sensitive areas of a patient's face, a seal-forming structure that may be effective in one area of ​​the patient's face may not be appropriate in another area. For example, a seal on swimming goggles that covers the patient's forehead may not be suitable for use on the patient's nose.

[0038] Certain seal-forming structures may be designed for mass manufacturing so that one design can fit and be comfortable and effective for a wide range of different face shapes and sizes. To the extent there is a mismatch between the shape of a patient's face and the seal-forming structure of a mass-manufactured patient interface, one or both must adapt to form a seal.

[0039] One type of seal-forming structure extends around the periphery of the patient interface and is intended to seal against the patient's face when a force is applied to the patient interface with the seal-forming structure in facing engagement with the patient's face. The seal-forming structure may include an air or fluid filled cushion, or a molded or formed surface of a resilient sealing element made of an elastomer such as rubber. With this type of seal-forming structure, if the fit is inadequate, there will be a gap between the seal-forming structure and the face, and additional force will be required to force the patient interface against the face in order to achieve a seal.

[0040] Another type of seal-forming structure incorporates a flap seal of thin material positioned around the periphery of the mask to provide a self-sealing action against the patient's face when positive pressure is applied within the mask. Similar to the previous types of seal-forming portions, if the fit between the face and the mask is not good, additional force may be required to achieve a seal, or the mask may leak. Furthermore, if the shape of the seal-forming structure does not match the shape of the patient, it may wrinkle or bend during use, causing leaks.

[0041] Another type of seal-forming structure may include friction-fit elements, such as for insertion into a nostril, however some patients find these uncomfortable.

[0042] A series of patient interface seal forming structure technologies are disclosed in the following patent applications: WO 1998 / 004310; WO 2006 / 074513; WO 2010 / 135785.

[0043] One form of nasal pillow is found in the Adam Circuit manufactured by Puritan Bennett, Inc. Another nasal pillow or nasal spray is the subject of U.S. Patent 4,782,832 (Trimble et al.), assigned to Puritan-Bennett Corporation.

[0044] ResMed Inc. has manufactured the following products incorporating nasal pillows: SWIFT™ nasal pillows, SWIFT™ II nasal pillows, SWIFT™ LT nasal pillows, SWIFT™ FX nasal pillows, and MIRAGE LIBERTY™ full face mask. Examples of nasal pillows are described in the following patent applications: International Patent Application WO 2004 / 073778 (describing other aspects of the SWIFT™ nasal pillows), U.S. Patent Application 2009 / 0044808 (describing other aspects of the SWIFT™ LT nasal pillows); International Patent Applications WO 2005 / 063328 and WO 2006 / 130903 (describing other aspects of the MIRAGE LIBERTY™ full face mask); International Patent Application WO 2009 / 052560 (describing other aspects of the SWIFT™ FX nasal pillows).

[0045] Positioning and stabilizing structures

[0046] The seal-forming structure of a patient interface for positive pressure therapy is subjected to a corresponding force of air pressure that is intended to break the seal. Therefore, a variety of techniques have been used to position the seal-forming structure and maintain it in a sealing relationship with the appropriate portion of the face. When comparing different positioning and stabilization techniques, many factors can be considered. These include: how effective the technique is in maintaining the seal-forming structure in a desired position and in sealing engagement with the face during use of the patient interface; how comfortable the interface is for the patient; whether the patient feels intrusive and / or claustrophobic when wearing the patient interface; and aesthetic appeal.

[0047] One technique is to use an adhesive, see, for example, US Patent Application Publication No. US2010 / 0000534.

[0048] Another technique is to use one or more straps and / or stabilizing straps. Many of these straps suffer from one or more problems of poor fit, bulkiness, discomfort, and inconvenience in use.

[0049] Pressurized air duct

[0050] In one type of treatment system, a pressurized air flow is provided to a patient interface through a conduit in an air circuit that is fluidly connected to the patient interface at a location in front of the patient's face when the patient interface is positioned on the patient's face during use. The conduit may extend forward from the patient interface away from the patient's face.

[0051] Pressurized air ducts for positioning / stabilizing seal-forming structures

[0052] Another type of treatment system includes a patient interface in which the tube that delivers pressurized air to the patient's airway also serves as part of a headgear to position and stabilize the seal-forming portion of the patient interface at the appropriate portion of the patient's face. This type of patient interface may be referred to as having a "conduit headgear" or "headgear tube". Such a patient interface allows the conduit in the air circuit that provides a pressurized air flow from a respiratory pressure therapy (RPT) device to be connected to the patient interface at a location other than the front of the patient's face. An example of such a treatment system is disclosed in U.S. Patent Publication No. US2007 / 0246043, the contents of which are incorporated herein by reference, in which the conduit is connected to a tube in the patient interface via a port that is positioned on the top of the patient's head during use.

[0053] Ideally, a patient interface in combination with a headcuff would be comfortable for the patient to wear for extended periods of time while the patient is asleep, form an airtight and stable seal with the patient's face, and also be able to conform to a range of patient head shapes and sizes.

[0054] Respiratory Pressure Therapy (RPT) Devices

[0055] A respiratory pressure therapy (RPT) device can be used alone or as part of a system to deliver one or more of the above-mentioned multiple therapies, such as by operating the device to generate an air flow for delivery to an interface of the airway. The air flow can be pressure-controlled (for respiratory pressure therapy) or flow-controlled (for flow therapies such as HFT). Therefore, an RPT device can also be used as a flow therapy device. Examples of RPT devices include CPAP devices and ventilators.

[0056] Air pressure generators are known in a range of applications, such as industrial-scale ventilation systems. However, air pressure generators for medical applications have specific requirements that are not met by more general air pressure generators, such as reliability, size and weight requirements for medical devices. Furthermore, even devices designed for medical treatment may have disadvantages related to one or more of the following: comfort, noise, ease of use, efficacy, size, weight, manufacturability, cost and reliability.

[0057] An example of a special requirement for certain RPT devices is acoustic noise.

[0058] Table of noise output levels of existing RPT devices (one sample only, measured using the test method specified in ISO 3744 in CPAP mode at 10 cmH2O).

[0059] RPT device name A-weighted sound pressure level dB(A) Year (approximately) <![CDATA[C series Tango TM > 31.9 2007 <![CDATA[C Series Tango with Humidifier TM > 33.1 2007 <![CDATA[S8 Escape TM II]]> 30.5 2005 <![CDATA[With H4i TM S8 Escape humidifier TM II]]> 31.1 2005 <![CDATA[S9 AutoSet TM ]]> 26.5 2010 <![CDATA[S9 AutoSet with H5i Humidifier TM > 28.6 2010

[0060] One known RPT device for treating sleep-disordered breathing is the S9 Sleep Therapy System manufactured by ResMed Inc. Another example of an RPT device is a ventilator. ResMed's Stellar ventilator for adults and pediatrics is available. TM The series of ventilators can provide invasive and non-invasive non-dependent ventilation support to a range of patients for the treatment of a variety of conditions such as but not limited to NMD, OHS and COPD.

[0061] ResMed Elisée TM 150 ventilator and ResMed VS III TM Ventilators can provide support for invasive and non-invasive dependent ventilation for adult or pediatric patients for the treatment of a variety of conditions. These ventilators provide volume and pressure ventilation modes with single-limb circuits or double-limb circuits. RPT devices typically include a pressure generator, such as a motor-driven blower or a compressed gas reservoir, and are configured to supply an air flow to the patient's airway. In some cases, the air flow can be provided to the patient's airway at a positive pressure. The outlet of the RPT device is connected to a patient interface such as those described above via an air circuit.

[0062] Designers of devices may be faced with making numerous choices. Design criteria often conflict, meaning that some design choices are out of the ordinary or unavoidable. Furthermore, some aspects of comfort and efficacy may be highly sensitive to small subtle changes in one or more parameters.

[0063] Air circuit

[0064] An air circuit is a conduit or tube that is constructed and arranged to allow air flow to travel between two components of a respiratory therapy system (such as an RPT device and a patient interface) in use. In some cases, there may be separate branches of the air circuit for inhalation and exhalation. In other cases, a single branch air circuit is used for both inhalation and exhalation.

[0065] humidifier

[0066] Delivering an unhumidified air stream can result in airway drying. Using a humidifier with an RPT device and a patient interface produces humidified gas that minimizes drying of the nasal mucosa and increases patient airway comfort. Additionally, in colder climates, warm air typically applied to the facial area in and around the patient interface is more comfortable than cold air.

[0067] Many artificial humidification devices and systems are known, however they do not meet the special requirements of medical humidifiers.

[0068] Medical humidifiers are used to increase the humidity and / or temperature of an air stream relative to ambient air when needed, typically where a patient is asleep or resting (e.g., in a hospital). Medical humidifiers for bedside placement can be small. A medical humidifier can be configured to humidify and / or heat only the air stream delivered to the patient, without humidifying and / or heating the patient's surroundings. For example, room-based systems (e.g., saunas, air conditioners, or evaporative coolers) can also humidify the air inhaled by the patient, however these systems also humidify and / or heat the entire room, which can be uncomfortable for the occupants. In addition, medical humidifiers can have more stringent safety constraints than industrial humidifiers.

[0069] Although many medical humidifiers are known, they may have one or more disadvantages. Some medical humidifiers may provide inadequate humidification and may be difficult or inconvenient for some patients to use.

[0070] Data Management

[0071] There may be many clinical reasons to obtain data to determine whether a patient on prescribed therapy with a respiratory therapy is "compliant," such as if the patient has used their RPT device in accordance with one or more "compliance rules." One example of a compliance rule for CPAP therapy is that a patient needs to use the RPT device for at least four hours per night for 21 out of 30 consecutive days to be considered compliant. To determine a patient's compliance, a provider of the RPT device, such as a healthcare provider, may manually obtain data describing a patient's therapy using the RPT device, calculate usage over a predetermined time period, and compare to the compliance rules. Once the healthcare provider has determined that the patient has used their RPT device in accordance with the compliance rules, the healthcare provider may notify third parties that the patient is compliant.

[0072] There may be other aspects of therapy in which transmitting therapy data to a third party or external system may benefit the patient.

[0073] Existing processes for transmitting and managing this data may be one or more of costly, time consuming, and prone to errors.

[0074] Ventilation technology

[0075] Some forms of therapeutic systems may include a vent to allow flushing of exhaled carbon dioxide. The vent may allow gas to flow from the interior space of the patient interface (eg, a plenum) to the outside of the patient interface (eg, to the environment).

[0076] The vent may include an orifice through which gas may flow when the mask is in use. Many such vents are noisy. Other vents may become blocked during use and thus provide inadequate flushing. Some vents may disturb the sleep of the patient's 1000 bed partner 1100, for example, by noise or concentrated airflow.

[0077] ResMed Ltd. has developed many improved mask ventilation technologies, see, for example, International Patent Application Publication No. WO 1998 / 034665; International Patent Application Publication No. WO 2000 / 078381; U.S. Patent No. 6,581,594; U.S. Patent Application Publication No. US 2009 / 0050156; U.S. Patent Application Publication No. 2009 / 0044808.

[0078] Noise table of existing masks (ISO 17510-2:2007, pressure of 10cmH2O at 1m)

[0079]

[0080]

[0081] (*One sample only, measured at 10 cmH2O in CPAP mode using the test method specified in ISO 3744)

[0082] The sound pressure values ​​for each object are listed below

[0083]

[0084] Screening, diagnostic and surveillance systems

[0085] Polysomnography (PSG) is a conventional system for diagnosing and monitoring cardiopulmonary disorders, and usually involves clinical experts to apply the system. PSG usually involves placing 15 to 20 contact sensors on the patient to record various body signals, such as electroencephalogram (EEG), electrocardiogram (ECG), electrooculogram (EOG), electromyogram (EMG), etc. PSG for sleep apnea involves two nights of observation of the patient in the clinic, one night for pure diagnosis, and the second night for titration of treatment parameters by the clinician. Therefore, PSG is both expensive and inconvenient. In particular, it is not suitable for home screening / diagnosis / monitoring of sleep apnea.

[0086] Screening and diagnosis generally describe the identification of a condition based on its signs and symptoms. Screening generally gives a true / false result indicating whether a patient's SDB is severe enough to warrant further testing, whereas diagnosis can yield clinically actionable information. Screening and diagnosis tend to be one-time processes, whereas monitoring the progression of a condition can continue indefinitely. Some screening / diagnosis systems are only suitable for screening / diagnosis, while some can also be used for monitoring.

[0087] A clinical expert may be able to adequately screen, diagnose, or monitor a patient based on visually observed PSG signals. However, there are situations where the clinical expert does not have the time or cannot afford the cost of a clinical expert. Different clinical experts may have different opinions on a patient's condition. Furthermore, a given clinical expert may apply different criteria at different times. Summary of the invention

[0088] The present technology is directed to providing medical devices for screening, diagnosing, monitoring, mitigating, treating or preventing breathing disorders that have improved one or more of comfort, cost, efficacy, ease of use and manufacturability.

[0089] A first aspect of the present technology relates to a device for screening, diagnosing, monitoring, mitigating, treating or preventing a respiratory disorder.

[0090] Another aspect of the present technology relates to methods for screening, diagnosing, monitoring, mitigating, treating or preventing breathing disorders.

[0091]

[0013] An aspect of some forms of the present technology is for providing methods and / or apparatus for improving patient compliance with respiratory therapy.

[0092] One form of the present technology includes an apparatus for delivering pressurized air or breathable gas to a patient. The apparatus may include a flow generator configured to generate an air flow. The patient interface may be constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway. The patient interface may be configured to deliver pressurized air or breathable gas to the patient's airway for respiratory therapy. An air delivery tube may be coupled between the flow generator and the patient interface to deliver a first portion of the air flow from the flow generator to the patient interface as pressurized air or breathable gas. The supplemental flow device may be configured to deliver a second portion of the air flow as a supplemental activity for respiratory therapy.

[0093] An aspect of one form of the present technology is that the supplemental flow device may be configured to deliver a second portion of the air flow away from the airway of the patient.

[0094]

[0013] An aspect of one form of the present technology is that the supplemental flow device may be configured to deliver a second portion of the air flow to an exterior of the patient interface.

[0095] In another aspect of one form of the present technology, the supplemental flow device may be configured to deliver a second portion of the air flow to the patient's skin.

[0096] Another aspect of one form of the present technology is that the supplemental flow device is configured to target discrete locations of the patient's skin.The second portion of the air flow can stimulate a response in the patient that forms at least part of an active supplemental therapy.

[0097] Another aspect of one form of the present technology is that the supplemental flow device can be configured to diffuse the second portion of the air flow over the patient's skin. This may change the environment around the patient.

[0098] Another aspect of one form of the present technology is that a single air flow is generated in the air tube from the flow generator, and the supplemental flow device is configured to divert a portion of air from the single air flow to form a second portion of the air flow.

[0099] Another aspect of one form of the present technology is that the supplemental flow device causes the air flow from the flow generator to be a plurality of flows, wherein one flow comprises a first portion of the air flow and a second flow comprises a second portion of the air flow. According to one form of the technology, the flow generator generates a single flow that is then divided into a plurality of flows. In one form, the flow generator is configured to generate separate flows by separate components within the unit or by separate stand-alone units.

[0100] Another aspect of one form of the present technology is that the patient interface includes a frame configured to conform to the shape of the patient's face. The supplemental flow device can form a part of the patient interface. The supplemental flow device can also be arranged in the frame to direct at least a portion of the air flow away from the patient's airway.

[0101] Another aspect of one form of the present technology is that the supplemental flow device and the air delivery tube are coupled together via a pathway provided on a frame or other component of the patient interface.

[0102] Another aspect of one form of the present technology may include more than one supplemental flow device for delivering the second portion of the air flow toward more than one location distal to the airway of the patient.

[0103] Another aspect of one form of the present technology is that more than one supplemental flow device can be used to deliver more than one active supplemental therapy to a patient. The second portion of the air flow can be configured to stimulate a response in the patient and / or a passive supplemental therapy, wherein the second portion of the air flow or a portion thereof can change the environment around the patient.

[0104] In another aspect of one form of the present technology, the supplemental flow device includes an orifice array configured to deflect a second portion of the air flow away from the airway of the patient.

[0105] Another aspect of one form of the present technology is that the device also includes a flow regulator valve for regulating a second portion of the air flow flowing to the patient, the flow regulator being configured to move between an open state allowing airflow therethrough and a closed state blocking airflow therethrough, wherein the state of the flow regulator valve between the open state and the closed state depends on the orientation of the device.

[0106]

[0013] Another aspect of one form of the present technology is that the flow regulator valve may be arranged to move between a closed state and an open state under the action of gravity.

[0107] One form of the present technology includes a patient interface for delivering pressurized air or breathable gas to a patient. The patient interface can be constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway to deliver the pressurized air or breathable gas to the patient's airway for respiratory therapy. The patient interface can also include a supplemental flow device. The supplemental flow device can be configured to deflect at least a portion of the pressurized air or breathable gas as a supplemental activity for respiratory therapy.

[0108]

[0013] In one aspect of one form of the present technology, the supplemental flow device may be configured to deflect pressurized air or breathable gas away from the airway of the patient.

[0109]

[0013] In one aspect of one form of the present technology, the supplemental flow device may be configured to deliver the offset pressurized air or breathable gas to the patient's skin outside of the patient interface.

[0110] Another aspect of one form of the present technology is that the supplemental flow device can be configured to target discrete locations of the patient's skin.The deflected air flow can stimulate a response in the patient that forms at least part of an active supplemental therapy.

[0111]

[0013] Another aspect of one form of the present technology is that the supplemental flow device may be configured to diffuse the deflected air flow over the patient's skin to alter the environment around the patient.

[0112] Another aspect of one form of the present technology is that the offset pressurized air or breathable gas may be directed to one or more specific areas of the patient's airway as a supplemental activity.

[0113] Another aspect of one form of the present technology is that the patient interface may include a frame configured to conform to the shape of the patient's face. The supplemental flow device may form part of the patient interface. The supplemental flow device may also be arranged in the frame to direct at least a portion of the air flow away from the patient's airway.

[0114] In another aspect of one form of the present technology, the supplemental flow device includes a path disposed on a frame of the patient interface that directs flow from the air delivery tube.

[0115]

[0013] Another aspect of one form of the present technology is that a patient interface may include more than one supplemental flow device for biasing air flow toward more than one location away from the patient's airway.

[0116] Another aspect of one form of the present technology is that more than one supplemental flow device can be used to deliver more than one active supplemental therapy to a patient, wherein the offset airflow is configured to stimulate a response within the patient and / or a passive supplemental therapy, wherein the offset airflow can change the environment around the patient.

[0117]

[0013] In another aspect of one form of the present technology, the supplemental flow device may include an orifice array configured to deflect air flow away from the airway of the patient.

[0118] Another aspect of one form of the present technology is that the patient interface also includes a flow regulator valve for regulating a second portion of the air flow to the patient, the flow regulator being configured to move between an open state permitting airflow therethrough and a closed state blocking airflow therethrough, wherein the state of the flow regulator valve between the open state and the closed state depends on the orientation of the patient interface.

[0119]

[0013] Another aspect of one form of the present technology is that the flow regulator valve may be arranged to move between a closed state and an open state under the action of gravity.

[0120] One form of the present technology includes a flow regulator valve for use with an apparatus for delivering pressurized air or breathable gas to a patient for respiratory therapy, the flow regulator valve being configured to regulate a flow of air to the patient as a supplemental activity to the respiratory therapy, the flow regulator being configured to move between an open state permitting airflow therethrough and a closed state blocking airflow therethrough, wherein the state of the flow regulator valve between the open state and the closed state depends on an orientation of the apparatus.

[0121] Another aspect of one form of the present technology is that the flow regulator valve is arranged to move between a closed state and an open state under the action of gravity.

[0122] One form of the present technology includes a system for delivering pressurized air or breathable gas to a patient. The system may include a patient interface constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway. The patient interface may be configured to deliver pressurized air or breathable gas to the patient's airway for respiratory therapy. A flow generator may be configured to generate an air flow. An air delivery tube may be coupled between the flow generator and the patient interface to deliver a first portion of the air flow to the patient interface as pressurized air or breathable gas. A supplemental flow device may be configured to deliver a second portion of the air flow away from the patient's airway.

[0123] In one aspect of one form of the present technology, the system may further include a sensory monitoring and stimulation unit. The system may further include a controller configured relative to the flow generator to set the operation of the supplemental flow device.

[0124] Another aspect of one form of the present technology is that the sensory monitoring and stimulation unit may be coupled to one or more sensors configured to detect physiological data of the patient. The controller may be configured to set the operation of the supplemental flow device based on signals from the one or more sensors.

[0125] Another aspect of one form of the present technology is that the sensory monitoring and stimulation unit can be coupled with one or more sensors configured to detect data of the patient's sleeping environment. The controller can be configured to set the operation of the supplemental flow device based on signals from the one or more sensors.

[0126]

[0013] Another aspect of one form of the present technology is that the supplemental flow device may be configured to deliver a second portion of the air flow to an exterior of the patient interface.

[0127] In another aspect of one form of the present technology, the supplemental flow device may be configured to deliver a second portion of the air flow to the patient's skin.

[0128] Another aspect of one form of the present technology is that the supplemental flow device can be configured to target discrete locations of the patient's skin.The second portion of the air flow can stimulate a response in the patient that forms at least part of an active supplemental therapy.

[0129] In another aspect of one form of the present technology, the supplemental flow device may be configured to diffuse a second portion of the air flow over the patient's skin to alter the environment surrounding the patient.

[0130] Another aspect of one form of the present technology is that the patient interface may include a frame configured to conform to the shape of the patient's face. The supplemental flow device may form part of the patient interface. The supplemental flow device may also be arranged in the frame to direct at least a portion of the air flow away from the patient's airway.

[0131]

[0013] Another aspect of one form of the present technology is that the supplemental flow device and the air delivery tube may be coupled together via a pathway disposed on a frame of a patient interface.

[0132]

[0013] Another aspect of one form of the present technology is that the system may include more than one supplemental flow device for delivering the second portion of the air flow toward more than one location distal to the airway of the patient.

[0133] Another aspect of one form of the present technology is that more than one supplemental flow device can be used to deliver more than one active supplemental therapy to the patient. The second portion of the air flow can be configured to stimulate a response in the patient and / or a passive supplemental therapy, wherein the offset airflow can change the environment around the patient.

[0134]

[0013] In another aspect of one form of the present technology, the supplemental flow device may include an orifice array configured to deflect air flow away from the airway of the patient.

[0135] One form of the present technology includes a method for delivering pressurized air or breathable gas to a patient. The method may include arranging a patient interface to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway. The method may also include generating an air flow and delivering a first portion of the air flow to the patient interface as pressurized air or breathable gas. The method may also include delivering the pressurized air or breathable gas to the patient's airway via the patient interface for respiratory therapy. The method may also include delivering a second portion of the gas flow as a supplemental activity to the respiratory activity.

[0136] An aspect of one form of the present technology is that the supplemental flow device may be configured to deliver a second portion of the air flow away from the airway of the patient.

[0137]

[0013] An aspect of one form of the present technology includes delivering a second portion of the air flow to an exterior of the patient interface.

[0138] Another aspect of one form of the present technology includes directing a second portion of the air flow onto the patient's skin.

[0139] Another aspect of one form of the present technology is directing a second portion of the air flow to one or more specific areas of the patient's airway as a supplemental activity.

[0140] Another aspect of one form of the present technology includes sensing physiological data of the patient.A second portion of the air flow may be delivered to the exterior of the patient interface and / or directed onto the patient's skin in response to the sensed physiological data.

[0141] Another aspect of one form of the present technology includes sensing a patient's sleeping environment. A second portion of the air flow may be delivered to the exterior of the patient interface and / or directed onto the patient's skin in response to the sensed sleeping environment.

[0142] Another aspect of one form of the present technology is a patient interface that is molded or otherwise configured to have a peripheral shape that is complementary to the peripheral shape of the intended wearer.

[0143]

[0011] One aspect of one form of the present technology is a method of making a device.

[0144] Another aspect of one form of the present technology is a method of constructing and attaching a positioning and stabilizing structure to a first pad or a second pad.

[0145] An aspect of some forms of the present technology is a medical device that is easy to use, for example, by a person without medical training, a person with limited dexterity, vision, or a person with limited experience in using this type of medical device.

[0146] One aspect of one form of the present technology is a portable RPT device that can be carried by a person (e.g., a family member of the person).

[0147] One aspect of one form of the present technology is a patient interface that can be cleaned at the patient's home, such as in soapy water, without the need for specialized cleaning equipment. One aspect of one form of the present technology is a humidifier water tank that can be cleaned at the patient's home, such as in soapy water, without the need for specialized cleaning equipment.

[0148] The described methods, systems, devices, and apparatus may be implemented to improve the functionality of a processor, such as a processor of a dedicated computer, a respiratory monitor, and / or a respiratory therapy device. In addition, the described methods, systems, devices, and apparatus may provide improvements in the art of automated management, monitoring, and / or treatment of respiratory conditions, including, for example, sleep-disordered breathing.

[0149] Of course, parts of these aspects may form sub-aspects of the present technology. In addition, sub-aspects and / or various aspects of each aspect may be combined in various ways, and also constitute additional aspects or sub-aspects of the present technology.

[0150] Other features of the present technology will become apparent from consideration of the information contained in the following detailed description, abstract, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0151] The present technology is illustrated by way of example and not limitation in the figures of the accompanying drawings in which like reference numerals refer to similar elements, including:

[0152] Respiratory therapy systems

[0153] Figure 1A A system is shown including a patient 1000 wearing a patient interface 2000 in the form of nasal pillows, receiving a positive pressure air supply from an RPT device 3000. Air from the RPT device 3000 is humidified in a humidifier 4000 and passed along an air circuit 3170 to the patient 1000. A bed partner 1100 is also shown. The patient sleeps in a supine sleeping position.

[0154] Figure 1B A system is shown including a patient 1000 wearing a patient interface 2000 in the form of a nasal mask, receiving a positive pressure air supply from an RPT device 3000. Air from the RPT device is humidified in a humidifier 4000 and passed along an air circuit 3170 to the patient 1000.

[0155] Figure 1C A system is shown including a patient 1000 wearing a patient interface 2000 in the form of a full face mask, receiving a positive pressure air supply from an RPT device 3000. Air from the RPT device is humidified in a humidifier 4000 and passed along an air circuit 3170 to the patient 1000. The patient sleeps in a side-lying sleeping position.

[0156] Respiratory system and facial anatomy

[0157] Figure 2A A schematic diagram of the human respiratory system including the nasal and oral cavities, larynx, vocal cords, esophagus, trachea, bronchi, lungs, alveolar sacs, heart, and diaphragm is shown.

[0158] Figure 2B A view of the human upper airway including the nasal cavity, nasal bones, lateral nasal cartilages, greater alar cartilages, nostrils, upper lip, lower lip, larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal cords, esophagus, and trachea is shown.

[0159] Figure 2C is a front view of the face with many of the surface anatomical features identified, including the upper lip, upper lip vermilion, lower lip vermilion, lower lip, mouth width, medial canthus, nasal wing, nasolabial groove, and lip corner point. The directions of superior, inferior, radially inward, and radially outward are also indicated.

[0160] Figure 2Dis a side view of the head with many of the surface anatomical features labeled, including the glabella, nasal bridge point, nasal prominence point, subnasal point, upper lip, lower lip, supramental point, nasal ridge, alar ridge point, supraauricular base point, and subauricular base point. The superior-inferior and anterior-posterior directions are also indicated.

[0161] Figure 2E is another lateral view of the head. The approximate location of the Frankfort horizontal plane and the nasolabial angle are indicated. The coronal plane is also shown.

[0162] Figure 2F A bottom view of the nose is shown with many features identified, including the nasolabial folds, lower lip, vermilion of the upper lip, nostrils, subnasal point, columella, pronasal point, long axis of the nostrils, and midsagittal plane.

[0163] Patient Interface

[0164] Figure 3A A patient interface in the form of a nasal mask is shown.

[0165] Figure 3B A view of a plenum 2200 is shown, showing a radial plane and a medial contact plane.

[0166] Figure 3C Shows Figure 3B A view of the rear portion of the plenum chamber. The view is oriented perpendicular to the median contact plane. Figure 3D The radial plane in the middle bisects the plenum into left and right sides.

[0167] Figure 3D Shown through Figure 3C The cross section of the gas-filled chamber is Figure 3C 2220 and the lower point 2230. The middle contact plane may be a tangent line at the upper and lower points depending on the geometry of the cushion in this area.

[0168] Figure 3E Shows Figure 3B The inflatable chamber 2200 is in the position of use on the face. When the inflatable chamber is in the use position, the sagittal plane of the inflatable chamber 2200 substantially coincides with the central sagittal plane of the face. When the inflatable chamber is in the use position, the median contact plane generally corresponds to the "plane of the face". Figure 3E In FIG. 2 , the inflation chamber 2200 is the inflation chamber of the nasal mask, and the upper point 2220 is located approximately on the bridge of the nose, while the lower point 2230 is located on the upper part of the lip.

[0169] Figure 3F A patient interface with a catheter tip cover is shown.

[0170] RPT Device

[0171] Figure 4A An RPT device is shown.

[0172] Figure 4B is a schematic diagram of the pneumatic path of the RPT device. The directions of upstream and downstream are indicated with reference to the blower and the patient interface. The blower is defined as being upstream of the patient interface and the patient interface is defined as being downstream of the blower, regardless of the actual flow direction at any particular moment. Objects within the pneumatic path between the blower and the patient interface are downstream of the blower and upstream of the patient interface.

[0173] Figure 4C is a schematic diagram of the electrical components of an RPT device.

[0174] Figure 4C-1 is a schematic diagram illustrating the interconnection of the various electrical components of the RPT device.

[0175] humidifier

[0176] Figure 5A An isometric view of a humidifier is shown.

[0177] Figure 5B An isometric view of the humidifier is shown, showing the humidifier reservoir 4110 removed from the humidifier reservoir base 4130.

[0178] Respiratory waveform

[0179] Figure 6 A model typical breathing waveform of a sleeping person is shown.

[0180] Complementary therapies

[0181] Figure 7 is a flow chart illustrating an apparatus for providing respiratory pressure therapy and supplemental therapy.

[0182] Fig. 8A An apparatus for providing respiratory pressure therapy and supplemental therapy is shown in use.

[0183] Figure 8B An apparatus for providing respiratory pressure therapy and supplemental therapy is shown in use.

[0184] Figure 8C-1 A schematic diagram showing a double branch tube for splitting gas flow from a single tube connected to a flow generator; and Figure 8C-2A schematic diagram showing a flow generator connected to two separate tubes for dividing the gas flow from the flow generator.

[0185] Fig. 9 An apparatus for providing respiratory pressure therapy and supplemental therapy is shown in use.

[0186] FIG. 10A to FIG. 10C A first embodiment of a flow regulator for providing supplemental therapy is shown, wherein: Fig. 10A shows a cross-sectional elevation view of a flow regulator; and Fig. 10B and Fig. 10C A cross-sectional side view of a schematic representation of a flow regulator is shown.

[0187] Fig.11 A cross-sectional elevation view of a second version of the first embodiment of the flow regulator is shown.

[0188] FIG. 12A to FIG. 12C Shown is a front view of a schematic representation of a second version of the first embodiment of the flow regulator.

[0189] Fig.13 Shown is a front view of a schematic representation of a second version of the first embodiment of the flow regulator.

[0190] Figures 14A to 14C A front view of a second embodiment of a flow regulator for providing supplemental therapy is shown.

[0191] FIG. 15A to FIG. 15C A front view of a second version of a second embodiment of a flow regulator for providing supplemental therapy is shown. DETAILED DESCRIPTION

[0192] Before describing the present technology in more detail, it should be understood that the technology is not limited to the specific examples described herein, which may vary. It should also be understood that the terminology used in the present disclosure is only for the purpose of describing the specific examples discussed herein, and is not intended to be limiting.

[0193] The following description is provided about each instance that can share one or more common characteristics and / or features. It should be understood that one or more features of any one instance can be combined with one or more features of another instance or other instances. In addition, any single feature or combination of features in any instance can constitute another instance.

[0194] therapy

[0195] In one form, the present technology includes a method for treating a breathing disorder comprising applying positive pressure to an entrance to the airway of a patient 1000 .

[0196] In certain examples of the present technology, a positive pressure air supply is provided to the patient's nasal passages via one or both nostrils.

[0197] In certain examples of the present technology, mouth breathing is limited, restricted, or prevented.

[0198] Respiratory therapy systems

[0199] In one form, the present technology includes a respiratory therapy system for treating a respiratory disorder. The respiratory therapy system may include an RPT device 3000 for supplying an air flow to a patient 1000 via an air circuit 3170 and a patient interface 2000 or 2800 .

[0200] Patient Interface

[0201] According to one aspect of the present technology, Figure 3A The non-invasive patient interface 2000 shown includes the following functional aspects: a seal-forming structure 2100, an inflatable chamber 2200, a positioning and stabilizing structure 2300, a vent 2400, a connection port 2600 for connecting to a form of air circuit 3170, and a forehead support 2700. In some forms, the functional aspects can be provided by one or more physical components. In some forms, one physical component can provide one or more functional aspects. In use, the seal-forming structure 2100 is arranged to surround the entrance of the patient's airway so as to maintain a positive pressure at the entrance of the airway of the patient 1000. Therefore, the sealed patient interface 2000 is suitable for the delivery of positive pressure therapy.

[0202] A patient interface 2000 according to one form of the present technology is constructed and arranged to provide an air supply at a positive pressure above ambient (eg, at least 2, 4, 6, 10, or 20 cmH2O relative to ambient).

[0203] Sealing structure

[0204] In one form of the present technology, the seal-forming structure 2100 provides a target seal-forming area and may additionally provide a cushioning function. The target seal-forming area is the area on the seal-forming structure 2100 where sealing is likely to occur. The area where sealing actually occurs—the actual sealing surface—can vary over time and from patient to patient within a given course of treatment, depending on a number of factors including, for example, where the patient interface is placed on the face, the tension in the positioning and stabilizing structures, and the shape of the patient's face.

[0205] In one form, the target seal-forming area is located on an outer surface of the seal-forming structure 2100 .

[0206] In some forms of the present technology, the seal-forming structure 2100 is comprised of a biocompatible material such as silicone rubber.

[0207] The seal-forming structure 2100 in accordance with the present technology may be formed from a soft, flexible and resilient material such as silicone.

[0208] In certain forms of the present technology, a system is provided that includes more than one seal-forming structure 2100, each seal-forming structure 2100 being configured to correspond to a different range of sizes and / or shapes. For example, the system may include one form of seal-forming structure 2100 that is suitable for large-sized heads but not for small-sized heads, and another that is suitable for small-sized heads but not for large-sized heads.

[0209] Sealing mechanism

[0210] In one form, the seal forming structure includes a sealing flange that utilizes a pressure-assisted sealing mechanism. In use, the sealing flange can readily respond to the system positive pressure acting on its underside within the interior of the plenum 2200 to urge it into tight sealing engagement with the face. The pressure-assist mechanism can work in conjunction with the elastic tension in the positioning and stabilizing structure.

[0211] In one form, the seal forming structure 2100 includes a sealing flange and a support flange. The sealing flange includes a relatively thin member having a thickness of less than about 1 mm, such as about 0.25 mm to about 0.45 mm, which extends around the periphery of the plenum 2200. The support flange can be relatively thicker than the sealing flange. The support flange is disposed between the sealing flange and the edge of the plenum 2200 and extends at least partially around the periphery. The support flange is a spring-like element or includes a spring-like element and serves to support the sealing flange to prevent it from bending during use.

[0212] In one form, the seal-forming structure may include a compression seal portion or a gasket seal portion. In use, the compression seal portion or the gasket seal portion is constructed and arranged to be in a compressed state, for example as a result of elastic tension in the positioning and stabilizing structure.

[0213] In one form, the seal-forming structure includes a tensioning portion. In use, the tensioning portion is maintained in tension, for example, by an adjacent area of ​​the sealing flange.

[0214] In one form, the seal-forming structure includes a region having a sticky or adhesive surface.

[0215] In certain forms of the present technology, the seal-forming structure may include one or more of a pressure-assisted sealing flange, a compression sealing portion, a gasket sealing portion, a tensioning portion, and a portion having a tacky or adhesive surface.

[0216] Nose bridge or nasal ridge area

[0217] In one form, the non-invasive patient interface 2000 includes a seal-forming structure that, in use, forms a seal over the nasal bridge or nasal ridge region of the patient's face.

[0218] In one form, the seal-forming structure comprises a saddle-shaped region configured to form a seal over a nasal bridge region or over a nasal ridge region of a patient's face in use.

[0219] Upper lip area

[0220] In one form, the non-invasive patient interface 2000 includes a seal-forming structure that, in use, forms a seal on the upper lip region (ie, upper lips) of the patient's face.

[0221] In one form, the seal-forming structure comprises a saddle-shaped region configured to form a seal on an upper lip region of a patient's face in use.

[0222] Chin area

[0223] In one form, the non-invasive patient interface 2000 includes a seal-forming structure that forms a seal on the chin region of the patient's face in use.

[0224] In one form, the seal-forming structure comprises a saddle-shaped region configured to form a seal on a chin region of a patient's face in use.

[0225] Frontal area

[0226] In one form, the seal-forming structure forms a seal on the forehead area of ​​the patient's face during use. In this form, the inflatable chamber can cover the eyes during use.

[0227] Nasal pillows

[0228] In one form, the seal-forming structure of the non-invasive patient interface 2000 comprises a pair of nasal puffs or pillows, each nasal puff or pillow being constructed and arranged to form a seal with a corresponding nostril of the patient's nose.

[0229] A nasal pillow according to one aspect of the present technology includes: a frustoconical body, at least a portion of which forms a seal on the underside of a patient's nose; a handle; and a flexible region located on the underside of the frustoconical body and connecting the frustoconical body to the handle. In addition, the structure to which the nasal pillows of the present technology are connected includes a flexible region adjacent to the base of the handle. These flexible regions can act in concert to facilitate a universal joint structure that accommodates displacement and angular relative movement of the frustoconical body and the structure to which the nasal pillows are connected. For example, the frustoconical body can be axially displaced toward the structure to which the handle is connected.

[0230] Pure nasal mask

[0231] In one form, the patient interface 2000 includes a seal-forming structure 2100 that is configured to seal around the entrance of the patient's nasal airways rather than around the patient's mouth. The seal-forming structure 2100 can be configured to seal against the upper portion of the patient's lips. The patient interface 2000 can leave the patient's mouth uncovered. The patient interface 2000 can deliver a supply of air or breathable gas to both nostrils of the patient 1000 rather than to the mouth. This type of patient interface can be identified as a pure nasal mask.

[0232] One form of a pure nasal mask according to the present technology is a mask conventionally identified as a "nasal mask" having a seal-forming structure 2100 configured to seal around the nose and over the bridge of the nose on the patient's face. The shape of the nasal mask can be generally triangular. In one form, the non-invasive patient interface 2000 includes a seal-forming structure 2100 that, in use, forms a seal against the upper lip area (e.g., above the lip), against at least a portion of the nasal ridge above the bridge of the patient's nose or the prognathism, and against the patient's face on each outer side of the patient's nose (e.g., near the patient's nasolabial grooves). Figure 1B The illustrated patient interface 2000 has this type of seal-forming structure 2100. The patient interface 2000 can deliver a supply of air or breathable gas to both nostrils of the patient 1000 through a single orifice.

[0233] Another form of a pure nasal mask may seal around the lower periphery of the patient's nose without engaging the user's nasal ridge. For example, this type of patient interface 2000 may be identified as a "nose support" mask, and the seal-forming structure 2100 may be identified as a "nose support cushion." In one form, for example, Figure 3FAs shown, the seal-forming structure 2100 is configured to form a seal with the lower surface of the nose around the nostrils in use. The seal-forming structure 2100 can be configured to seal around the patient's nostrils at the lower periphery of the patient's nose, including the lower surface and / or the front surface of the nasal prominence area of ​​the patient's nose and the sealing of the patient's nose wing. The seal-forming structure 2100 can form a seal on the upper lip of the patient. The shape of the seal-forming structure 2100 can be configured to match or fit closely to the lower side of the patient's nose, and may not contact the nasal bridge area of ​​the patient's nose or any part of the patient's nose above the nasal prominence. In one form of a nose pad cushion, the seal-forming structure 2100 includes a bridging portion that divides the opening into two orifices, and in use, each orifice supplies air or breathable gas to a corresponding one of the patient's nostrils. The bridging portion can be configured to contact the patient's columella or seal against the patient's columella in use. Alternatively, the seal-forming structure 2100 may include a single opening to provide air flow or breathable gas to both nostrils of the patient.

[0234] In some forms, a purely nasal mask may include nasal pillows as described above.

[0235] Nose and mouth mask

[0236] In one form, the patient interface 2000 includes a seal-forming structure 2100 that is configured to form a seal around the entrance of the patient's nasal airways and also around the patient's mouth. The seal-forming structure 2100 can be configured to form a seal against the patient's face at a location near the chin area. The patient interface 2000 can deliver a supply of air or breathable gas to both nostrils and the mouth of the patient 1000. This type of patient interface can be identified as a nose-to-mouth mask.

[0237] One form of a nose and mouth mask according to the present technology is a form that is traditionally identified as a "full face mask" having a seal-forming structure 2100 that is configured to seal around the nose, under the mouth, and over the bridge of the nose on the patient's face. The shape of the nose and mouth mask is generally triangular. In one form, the patient interface 2000 includes a seal-forming structure 2100 that, in use, forms a seal against the patient's chin area (which may include the patient's lower lip and / or the area directly below the lower lip), the patient's nose bridge or at least a portion of the nasal ridge above the nasal protrusion, and against the cheek area of ​​the patient's face. Figure 1C The patient interface 2000 shown is of this type. The patient interface 2000 can deliver a supply of air or breathable gas to the nostrils and mouth of the patient 1000 through a single orifice. This type of seal-forming structure 2100 can be referred to as a "nose-mouth cushion."

[0238] In another form, the patient interface 2000 includes a seal-forming structure 2100 that, in use, forms a seal against the lower surface and / or front surface of the nasal prominence portion of the patient's nose over the patient's chin region (which may include the patient's lower lip and / or an area directly below the lip), against the nasal wings of the patient's nose, and against the patient's face on each outer side of the patient's nose (e.g., near the patient's nasolabial grooves). The seal-forming structure 2100 may also form a seal against the patient's upper lip. A patient interface 2000 having this type of seal-forming structure may have a single opening configured to deliver a flow of air or breathable gas to both nostrils and the mouth of the patient, may have an orifice configured to provide air or breathable gas to the mouth and nostrils configured to provide air or breathable gas to the nostrils, or may have an orifice for delivering air to the patient's mouth and two nostrils for delivering air to the respective nostrils. This type of patient interface 2000 may have a nasal portion and an oral portion, with the nasal portion forming a seal against the patient's face in a position similar to a nasal mask.

[0239] In another form of a nose and mouth mask, a patient interface 2000 may include a seal-forming structure 2100 having a nasal portion including nasal pillows and an oral portion configured to form a seal against the patient's face around the patient's mouth.

[0240] In some forms, the seal-forming structure 2100 may have a nasal portion that is separate and distinct from the oral portion. In other forms, the seal-forming structure 2100 may form a continuous seal around the patient's nose and mouth.

[0241] It should be appreciated that the above examples of different forms of the patient interface 2000 do not constitute an exhaustive list of possible configurations. In some forms, the patient interface 2000 may include a combination of different features of the above examples of pure nasal masks and nasal and mouth masks.

[0242] Inflatable room

[0243] The plenum 2200 has a perimeter shaped to complement the surface contour of an average human face in the area where a seal will be formed in use. In use, the boundary edge of the plenum 2200 is positioned in close proximity to the adjacent surface of the face. Actual contact with the face is provided by the seal-forming structure 2100. The seal-forming structure 2100 may extend around the entire perimeter of the plenum 2200 in use. In some forms, the plenum 2200 and the seal-forming structure 2100 are formed from a single homogeneous sheet of material.

[0244] In some forms of the present technology, the plenum chamber 2200 does not cover the patient's eyes during use. In other words, the eyes are outside the pressurized volume defined by the plenum chamber. Such forms tend to be less obtrusive and / or more comfortable for the wearer, which can improve compliance with therapy.

[0245] In some forms of the present technology, the plenum 2200 is constructed of a transparent material (e.g., transparent polycarbonate). The use of a transparent material can reduce the obtrusiveness of the patient interface and help improve compliance with therapy. The use of a transparent material can help the clinician observe how the patient interface is positioned and functioning.

[0246] In some forms of the present technology, the plenum chamber 2200 is constructed of a translucent material. The use of a translucent material can reduce the obtrusiveness of the patient interface and help improve compliance with therapy.

[0247] In some forms, plenum 2200 is constructed of a rigid material such as polycarbonate. The rigid material may provide support for the seal-forming structure.

[0248] In some forms, the plenum 2200 is made of a flexible material (e.g., a soft, flexible, elastic material such as silicone, textile, foam, etc.). For example, in an example, it can be formed from a material having a Young's modulus of 0.4 GPa or less (e.g., foam). In some forms of the technology, the plenum 2200 can be made of a material having a Young's modulus of 0.1 GPa or less (e.g., rubber). In other forms of the technology, the plenum 2200 can be made of a material having a Young's modulus of 0.7 MPa or less (e.g., between 0.7 MPa and 0.3 MPa). An example of such a material is silicone.

[0249] Positioning and stabilizing structures

[0250] The seal-forming structure 2100 of a patient interface 2000 of the present technology may be maintained in a sealed position in use by a positioning and stabilising structure 2300. The positioning and stabilising structure 2300 may include and function as a "headgear" in that it engages the patient's head to maintain the patient interface 2000 in a sealed position. Figure 3A Examples of positioning and stabilizing structures are shown in .

[0251] In one form, the positioning and stabilizing structure 2300 provides a holding force that is at least sufficient to overcome the positive pressure in the plenum 2200 to lift the face (i.e., F 充气 ).

[0252] In one form, the positioning and stabilising structure 2300 provides a retaining force to overcome the effects of gravity on the patient interface 2000 .

[0253] In one form of the present technology, the positioning and stabilizing structure 2300 comprises a belt comprised of a laminate of a fabric patient contacting layer, a foam inner layer, and a fabric outer layer. In one form, the foam is porous to allow moisture (e.g., sweat) to pass through the belt. In one form, the fabric outer layer comprises a loop material partially engaged with a hook material.

[0254] In some forms of the present technology, the positioning and stabilizing structure 2300 includes an extendable strap, such as a resiliently extendable strap. For example, the strap can be configured to be in tension during use and direct a force to bring the seal-forming structure into sealing contact with a portion of the patient's face. In an example, the strap can be configured as a tie strap.

[0255] In one form of the present technology, the positioning and stabilizing structure includes a first strap that is constructed and arranged so that in use at least a portion of its lower edge passes above the supraauricular base of the patient's head and covers a portion of the parietal bone without covering the occipital bone.

[0256] In one form of the present technology applicable to a pure nasal mask or a full-face mask, the positioning and stabilizing structure includes a second strap that is constructed and arranged so that in use at least a portion of its upper edge passes below the subauricular base of the patient's head and covers the occipital bone of the patient's head or is located below the occipital bone of the patient's head.

[0257] In one form of the present technology applicable to a nasal-only mask or a full-face mask, the positioning and stabilizing structure includes a third strap constructed and arranged to interconnect the first strap and the second strap to reduce the tendency of the first strap and the second strap to separate from each other.

[0258] In some forms of the present technology, the positioning and stabilizing structure 2300 comprises a bendable and, for example, non-rigid belt. An advantage of this aspect is that the belt is more comfortable for the patient when the patient is sleeping.

[0259] In some forms of the present technology, the positioning and stabilising structure 2300 comprises a band configured to be breathable to allow moisture to pass through the band.

[0260] In certain forms of the present technology, a system is provided that includes more than one positioning and stabilizing structure 2300, each positioning and stabilizing structure 2300 being configured to provide retention forces to correspond to a different range of sizes and / or shapes. For example, the system may include one form of positioning and stabilizing structure 2300 that is suitable for large sized heads but not for small sized heads, while another form of positioning and stabilizing structure is suitable for small sized heads but not for large sized heads.

[0261] Catheter Tip

[0262] Catheter head sleeve

[0263] In some forms of the present technology, the positioning and stabilizing structure 2300 includes one or more head cuffs 2350 that deliver pressurized air received from a conduit forming part of the air circuit 3170 from the RPT device to the patient's airway, such as through the plenum 2200 and the seal-forming structure 2100. Figure 3F In the illustrated form of the present technology, the positioning and stabilizing structure 2300 includes two tubes 2350 that deliver air from the air circuit 3170 to the plenum chamber 2200. The tubes 2350 are configured to position and stabilize the seal-forming structure 2100 of the patient interface 2000 at an appropriate portion of the patient's face (e.g., nose and / or mouth) during use. This allows the conduit of the air circuit 3170 that provides the pressurized air flow to be connected to the connection port 2600 of the patient interface at a location other than the front of the patient's face, such as at the top of the patient's head.

[0264] exist Figure 3F In the illustrated form of the present technology, the positioning and stabilizing structure 2300 includes two tubes 2350, each tube 2350 being positioned on a different side of the patient's head in use, and extending over the respective ear (above the supra-auricular base on the patient's head) across the respective cheek region to a curved tube 2610 on the top of the head of the patient 1000. This form of technology may be advantageous because if the patient sleeps with their head turned sideways, and one of the tubes 2350 is compressed to block or partially block the flow of gas along that tube 2350, the other tube 2350 remains open to supply pressurized gas to the patient. In other examples of the technology, the patient interface 2000 may include a different number of tubes, such as one tube, or two or more tubes.

[0265] In one example where the patient interface has one tube 2350, the single tube 2350 is positioned on one side of the patient's head (e.g. across one cheek region) in use, and the strap forms part of the positioning and stabilising structure 2300 and is positioned on the other side of the patient's head (e.g. across the other region) in use to help secure the patient interface 2000 to the patient's head. For example, the tube 2350 and strap may each be under tension in use to help maintain the seal-forming structure 2100 in a sealing position.

[0266] In one form, the tube 2350 can be at least partially extendable so that the tube 2350 and the belt can be adjusted to substantially equal lengths when worn by a patient. This can allow for substantially symmetrical adjustment between the tube 2350 and the belt so that the seal-forming structure remains substantially in the middle.

[0267] exist Figure 3F In the illustrated technical form, two tubes 2350 are fluidly connected to each other and to the connection port 2600 at the upper end. In some examples, the two tubes 2350 are formed integrally, while in other examples, the tubes 2350 are formed separately, but connected in use and can be disconnected, such as for cleaning or storage. In the case of using separate tubes, they can be indirectly connected together, for example, each can be connected to a T-connector. The T-connector can have two arms / branches, each arm / branch can be fluidly connected to a corresponding one of the tubes 2350. Additionally, the T-connector can have a third arm or opening, which provides a connection port 2600 for fluid connection to the air circuit 3170 in use. The opening can be an inlet 2332 (see, for example, 7C) for receiving a pressurized air flow.

[0268] In some forms, the third arm of the T-connector may be substantially perpendicular to each of the first two arms.

[0269] In some forms, the third arm of the T-shaped connector may be formed obliquely relative to each of the first two arms.

[0270] In some forms, a Y-shaped connector may be used instead of a T-shaped connector. The first two arms may be angled relative to each other, and the third arm may be angled relative to the first two arms. The angled first two arms may resemble the shape of the patient's head so as to conform to that shape.

[0271] In some forms, at least one arm of the T-shaped connector (or Y-shaped connector) can be flexible. This can allow the connector to bend based on the shape of the patient's head and / or the forces in the positioning and stabilizing structure 2300.

[0272] In some forms, at least one arm of a T-shaped connector (or Y-shaped connector) may be at least partially rigidified. This may help maintain the shape of the connector so that a bend in the connector does not close off the airflow path.

[0273] Tube 2350 can be formed of a flexible material, such as an elastomer, for example, silicone or TPE, and / or formed of one or more textile and / or foam materials. Tube 2350 can have a preformed shape and can bend or move into another shape when a force is applied, but can return to the original preformed shape when the force is absent. Tube 2350 can be generally arcuate or curved in shape, approximating the contour of the patient's head between the top of the head and the nose or mouth area.

[0274] In some examples, the one or more tubes 2350 are crush resistant to resist clogging that may occur if crushed during use (e.g., if pressed between a patient's head and a pillow, especially if there is only one tube 2350). The tube 2350 can be formed to have sufficient structural rigidity to resist crushing, or can be as described in U.S. Pat. No. 6,044,844, the contents of which are incorporated herein by reference.

[0275] Each tube 2350 can be configured to receive air flow from a connection port 2600 on the top of the patient's head and deliver the air flow to the seal-forming structure 2100 at the entrance of the patient's airway. Figure 3F In the illustrated example, each tube 2350 is located in a path extending from the plenum chamber 2200 across the cheek area of ​​the patient and above the patient's ear to the curved tube 2610 during use. For example, the portion of each tube 2350 near the plenum chamber 2200 can cover the maxillary area of ​​the patient's head during use. Another portion of each tube 2350 can cover an area of ​​the patient's head that is above the supra-auricular base of the patient's head. Each tube 2350 can also be located on the patient's sphenoid and / or temporal bones and either or both of the patient's frontal and parietal bones. The curved tube 2610 can be located on the patient's parietal bone, on the frontal bone, and / or on the junction between them (e.g., the coronal suture) during use.

[0276] In certain forms of the present technology, the patient interface 2000 is configured such that the connection port 2600 can be positioned in a range of positions across the top of the patient's head so that the patient interface 2000 can be positioned to suit the comfort or fit of an individual patient. In some instances, the headcuff 2350 is configured to allow an upper portion of the patient interface 2000 (e.g., the connection port 2600) to move relative to a lower portion of the patient interface 2000 (e.g., the plenum 2200). That is, the connection port 2600 can be at least partially decoupled from the plenum 2200. In this way, the seal-forming structure 2100 can form an effective seal with the patient's face regardless of the location of the connection port 2600 on the patient's head (at least within a predetermined range of positions).

[0277] As described above, in some examples of the present technology, the patient interface 2000 includes a seal-forming structure 2100 in the form of a nose pad cushion that is generally positioned under the nose and seals to the lower periphery of the nose (e.g., a cushion under the nose). The positioning and stabilizing structure 2300 including the tube 2350 can be constructed and arranged to draw the seal-forming structure 2100 into the patient's face under the nose with a sealing force in a posterior and superior direction (e.g., a posterior-superior direction). Having a sealing force in a posterior-superior direction can cause the seal-forming structure 2100 to form a good seal against the lower periphery of the patient's nose and forward-facing surfaces of the patient's face, such as on either side of the patient's nose and above the patient's lips.

[0278] Catheter Tip Connection Port

[0279] In some forms of the present technology, the patient interface 2000 may include a connection port 2600 located near the upper, outer, or rear portion of the patient's head. Figure 3F In the illustrated form of the present technology, the connection port 2600 is located on the top of the patient's head (e.g., in an upper position relative to the patient's head). In this example, the patient interface 2000 includes an elbow 2610 that forms the connection port 2600. The elbow 2610 can be configured to be fluidly connected to the conduit of the air circuit 3170. The elbow 2610 can be configured to rotate relative to the positioning and stabilizing structure 2300 to at least partially disconnect the conduit from the positioning and stabilizing structure 2300. In some examples, the elbow 2610 can be configured to rotate around a substantially vertical rotation axis, and in some specific examples, by rotating around two or more axes. In some examples, the elbow can include a tube 2350 or be connected to the tube 2350 by a ball joint. In use, the connecting portion 2600 can be located in the sagittal plane of the patient's head.

[0280] A patient interface in which the connection port is not positioned in front of the patient's face may be advantageous, because some patients may find the conduit of the patient interface connected to the front of the patient's face unsightly and / or obtrusive. For example, the conduit of the patient interface connected to the front of the patient's face may be prone to conflict with bedding, particularly if the conduit extends downward from the patient interface in use. The form of the present technology including a patient interface having a connection port positioned above the patient's head in use can make it easier or more comfortable for the patient to lie or sleep in one or more of the following positions: a side-lying position, a supine position (e.g., on its back, generally facing upward) or a prone position (e.g., on its front, generally facing downward). In addition, connecting the conduit to the front portion of the patient interface may exacerbate a problem known as tube resistance, in which the conduit applies an undesirable force on the patient interface during movement of the patient's head or conduit, resulting in displacement away from the face. Tube resistance may not be a problem (wherein tube resistance is more likely to destroy the seal) when receiving force at a position above the patient's head rather than in front of the patient's face near the seal-forming structure.

[0281] Head sleeve fluid connection

[0282] The two tubes 2350 are fluidly connected to the inflatable chamber 2200 at their lower ends. In some forms of the technology, the connection between the tube 2350 and the inflatable chamber 2200 is achieved by the connection of two rigid connectors. The tube 2350 and the inflatable chamber 2200 can be configured to enable the patient to easily connect the two components together in a reliable manner. The tube 2350 and the inflatable chamber 2200 can be configured to provide tactile and / or auditory feedback in the form of a "reassuring click" or similar sound, so that the patient can easily know that each tube 2350 has been correctly connected to the inflatable chamber 2200. In one form, the tube 2350 is formed of silicone or textile material, and the lower end of each silicone tube 2350 is overmolded to a rigid connector made of, for example, polypropylene, polycarbonate, nylon, etc. The rigid connector on each tube 2350 may include a concave mating feature that is configured to connect with a convex mating feature on the inflatable chamber 2200. Alternatively, the rigid connector on each tube 2350 may include a male mating feature configured to connect to a female mating feature on the plenum 2200. In other examples, the tubes 2350 may each include a male or female connector formed from a flexible material, such as silicone or TPE, e.g., the same material from which the tubes 2350 are formed.

[0283] In other examples, compression seals are used to connect each tube 2350 to the plenum 2200. For example, a resiliently flexible (e.g., silicone) tube 2350 without a rigid connector can be configured to be subjected to extrusion to reduce its diameter so that it can be compressed into a port in the plenum 2200, and the inherent resilience of the silicone pushes the tube 2350 outwardly so as to seal the tube 2350 in the port in an airtight manner. Alternatively, in a hard-to-hard joint between the tube 2350 and the plenum 2200, each tube 2350 and / or the plenum 2200 can include a pressure-activated seal, such as a peripheral sealing flange. When pressurized gas is supplied through the tube 2350, the sealing flange can be pushed against the junction between the tube and the circumferential surface of the port or connector surrounding the plenum 2200 to form or enhance the seal between the tube 2350 and the plenum 2200.

[0284] Headband

[0285] In some forms, the positioning and stabilizing structure 2300 may include a headgear 2302 having at least one strap that can be worn by the patient to assist in properly orienting the seal-forming structure 2100 relative to the patient's face (e.g., to limit or prevent leakage).

[0286] As described above, some forms of headgear 2302 can be constructed of a textile material that can fit comfortably against the patient's skin. The fabric can be flexible to conform to various facial contours. Although the textile can include a stiffener along a selected length, this can limit the bending, flexing, and / or stretching of the headgear 2302.

[0287] In some forms, the headgear 2302 can be at least partially extensible. For example, the headgear 2302 can include elastic or similar extensible materials. For example, the entire headgear 2302 can be extensible, or selected portions can be extensible (or more extensible than surrounding portions). This can allow the headgear 2302 to stretch under tension, which can help provide a sealing force to the seal-forming structure 2100.

[0288] There are two types of headgear, four-point headgear 2302-1 (see Figure 3A ) and two-point headgear 2302-2 (see Figure 3F ).

[0289] Vent

[0290] In one form, the patient interface 2000 includes a vent 2400 constructed and arranged to allow flushing of exhaled gases (eg, carbon dioxide).

[0291] In some forms, the vent 2400 is configured to allow a continuous flow of ventilation from the interior of the plenum 2200 to the surrounding environment while the pressure within the plenum is positive relative to the surrounding environment. The vent 2400 is configured so that the ventilation flow is of a magnitude sufficient to reduce the patient's rebreathing of exhaled CO2 while maintaining a therapeutic pressure in the plenum during use.

[0292] One form of a vent 2400 according to the present technology includes a plurality of holes, for example, from about 20 to about 80 holes, or from about 40 to about 60 holes, or from about 45 to about 55 holes.

[0293] The vent 2400 may be located in the plenum chamber 2200. Alternatively, the vent 2400 is located in a decoupling structure (eg, a swivel).

[0294] Disconnection structure

[0295] In one form, patient interface 2000 includes at least one decoupling structure, such as a swivel or a ball and socket.

[0296] Connection Ports

[0297] The connection port 2600 allows connection to the air circuit 3170 .

[0298] Forehead support

[0299] In one form, the patient interface 2000 includes a forehead support 2700 .

[0300] Anti-suffocation valve

[0301] In one form, patient interface 2000 includes an anti-asphyxia valve.

[0302] Modularity

[0303] As described above, the cushions, headgear, and sleeves can have different styles, which can correspond to different uses (e.g., mouth breathing, nasal breathing, etc.). The patient or clinician can select certain combinations of cushions, headgear, and sleeves to optimize the effectiveness of the therapy and / or the comfort of the individual patient. An example of such a modular design is described in PCT / SG2022 / 050777, filed on October 28, 2022, the entire contents of which are incorporated herein by reference.

[0304] In some forms, different styles of cushions, headgear, and sleeves can be used interchangeably with each other to form different combinations of patient interfaces. This can be beneficial from a manufacturing perspective because fewer parts can be used to create a variety of patient interfaces. Additionally or alternatively, the various combinations can allow the patient to change the style of the patient interface without changing every component.

[0305] Air can be delivered to the patient in one of two main ways. In one example, the patient can be delivered to the patient through a head cannula 2350 (see, e.g., Figure 3F ) receives the pressurized air flow. This may be referred to as an "up tube" configuration, and the connection port may be positioned at the top of the patient's head. In other examples, the patient may receive the pressurized air flow via a conduit connected to the plenum 2200, such as via the connection port 2600 (see, e.g. Figure 3A ). This may be referred to as a "down tube" configuration, where the airflow conduit is located in front of the patient's face. Different patients may be more comfortable with one style of air delivery than with another style of air delivery (e.g., due to the patient's sleeping style). Therefore, it would be beneficial to allow a single style of patient interface to be used in either an "up tube" or "down tube" configuration.

[0306] The patient interface may be part of a modular assembly having various interchangeable components that the patient and / or clinician may swap out for one or more components for a different style. The following description describes various combinations that may be created by assembling the different components together.

[0307] RPT Device

[0308] The RPT device 3000 according to one aspect of the present technology includes mechanical, pneumatic and / or electrical components and is configured to execute one or more algorithms 3300, such as all or part of any of the methods described herein. The RPT device 3000 can be configured to generate an air flow for delivery to the airway of a patient, such as for treating one or more respiratory conditions described elsewhere in this document.

[0309] The RPT device 3000 can have an outer housing 3010 formed of two parts: an upper portion 3012 and a lower portion 3014. In addition, the outer housing 3010 can include one or more panels 3015. The RPT device 3000 includes a chassis 3016 that supports one or more internal components of the RPT device 3000. The RPT device 3000 can include a handle 3018.

[0310] The pneumatic path of the RPT device 3000 can include one or more air path items, such as an inlet air filter 3112, an inlet muffler 3122, a pressure generator 3140 capable of supplying positive pressure air (e.g., a blower 3142), an outlet muffler 3124, and one or more transducers 3270, such as a pressure sensor 3272 and a flow sensor 3274.

[0311] One or more of the air path items may be located within a removable unitary structure, which will be referred to as a pneumatic block 3020. The pneumatic block 3020 may be located within the outer housing 3010. In one form, the pneumatic block 3020 is supported by or formed as part of the chassis 3016.

[0312] like Figure 4C As shown, the RPT device 3000 may have a power supply 3210, one or more input devices 3220, a central controller 3230, a therapy device controller 3240, a pressure generator 3140, one or more protection circuits 3250, a memory 3260, a transducer 3270, a data communication interface 3280, and one or more output devices 3290. The electrical components 3200 may be mounted on a single printed circuit board assembly (PCBA) 3202. In an alternative form, the RPT device 3000 may include more than one PCBA 3202.

[0313] RPT device mechanical and pneumatic components

[0314] The RPT device may include one or more of the following components in an integral unit. In an alternative form, one or more of the following components may be located as respective separate units.

[0315] Air Filter

[0316] A RPT device according to one form of the present technology may include one air filter 3110, or multiple air filters 3110.

[0317] exist Figure 4B In one form shown, the inlet air filter 3112 is located at the beginning of the pneumatic path upstream of the pressure generator 3140.

[0318] exist Figure 4B In one form illustrated, an outlet air filter 3114 , such as an antimicrobial filter, is located between the outlet of the pneumatic block 3020 and the patient interface 2000 or 2800 .

[0319] Muffler

[0320] An RPT device according to one form of the present technology may include a muffler 3120, or a plurality of mufflers 3120.

[0321] In one form of the present technology (see, for example, Figure 4B ), the inlet muffler 3122 is located in the pneumatic path upstream of the pressure generator 3140.

[0322] In one form of the present technology, an outlet muffler 3124 is located in the pneumatic path between the pressure generator 3140 and the patient interface 2000 or 2800 .

[0323] Pressure generator

[0324] In one form of the present technology, the pressure generator 3140 for generating a positive pressure air flow or air supply is a controllable blower 3142. For example, the blower 3142 may include a brushless DC motor 3144 having one or more impellers. These impellers may be located in a volute. The blower is capable of delivering an air supply, for example, at a rate of up to about 120 liters per minute, at a positive pressure ranging from about 4 cmH2O to about 20 cmH2O, or in other forms up to about 30 cmH2O when delivering respiratory pressure therapy. The blower may be as described in any of the following patents or patent applications: U.S. Patent No. 7,866,944; U.S. Patent No. 8,638,014; U.S. Patent No. 8,636,479; and PCT Patent Application Publication No. WO 2013 / 020167, the contents of which are incorporated herein by reference in their entirety.

[0325] The pressure generator 3140 may be under the control of the therapy device controller 3240 .

[0326] In other forms, the pressure generator 3140 may be a piston driven pump, a pressure regulator connected to a high pressure source (eg, a compressed air reservoir), or a bellows.

[0327] Transducer

[0328] The transducer may be internal to the RPT device, or external to the RPT device. An external transducer may be located, for example, on or form part of an air circuit (e.g., a patient interface). The external transducer may be in the form of a non-contact sensor, such as a Doppler radar motion sensor that transmits or transfers data to the RPT device.

[0329] In one form of the present technology (see e.g. Figure 4B ), one or more transducers 3270 are located upstream and / or downstream of the pressure generator 3140. The one or more transducers 3270 can be constructed and arranged to generate a signal representative of a characteristic of the air flow, such as flow, pressure, or temperature at that point in the pneumatic path.

[0330] In one form of the present technology, one or more transducers 3270 may be located proximate to the patient interface 2000 or 2800 .

[0331] In one form, the signal from the transducer 3270 may be filtered, such as by low pass, high pass, or band pass filtering.

[0332] Flow Sensors

[0333] A flow sensor 3274 according to the present technology may be based on a differential pressure transducer, such as the SDP600 series differential pressure transducer from SENSIRION of Switzerland.

[0334] In one form, a signal generated by the flow sensor 3274 and representative of the flow rate is received by the central controller 3230 .

[0335] Pressure Sensors

[0336] A pressure sensor 3272 according to the present technology is positioned in fluid communication with the pneumatic path. An example of a suitable pressure sensor is a transducer from the ASDX series from Honeywell. An alternative suitable pressure sensor is a transducer from the NPA series from General Electric.

[0337] In one form, a signal generated by the pressure sensor 3272 and representative of the pressure is received by the central controller 3230 .

[0338] Motor speed transducer

[0339] In one form of the present technology, a motor speed transducer 3276 is used to determine the rotational speed of the motor 3144 and / or blower 3142. A motor speed signal from the motor speed transducer 3276 may be provided to the therapy device controller 3240. The motor speed transducer 3276 may be, for example, a speed sensor such as a Hall effect sensor.

[0340] Anti-spillback valve

[0341] like Figure 4B As shown, in one form of the present technology, an anti-spillback valve 3160 is located between the humidifier 4000 and the pneumatic block 3020. The anti-spillback valve is constructed and arranged to reduce the risk that water will flow upstream from the humidifier 4000 to, for example, the motor 3144.

[0342] RPT device electrical components

[0343] power supply

[0344] The power source 3210 may be located inside or outside the outer housing 3010 of the RPT device 3000 .

[0345] In one form of the present technology, the power supply 3210 provides power only to the RPT device 3000. In another form of the present technology, the power supply 3210 provides power to both the RPT device 3000 and the humidifier 4000.

[0346] like Figure 4C-1 As illustrated, power source 3210 can provide power to input device 3220, central controller 3230, output device 3290, and pressure generator 3140. Power source 3210 can also provide power to other components of RPT device 3000 (or humidifier 4000, as described above).

[0347] Input Devices

[0348] In one form of the present technology, the RPT device 3000 includes one or more input devices 3220 in the form of buttons, switches, or dials to allow a person to interact with the device. The buttons, switches, or dials may be physical devices, or software devices accessible via a touch screen. In one form, the buttons, switches, or dials may be physically connected to the external housing 3010, or in another form, may communicate wirelessly with a receiver electrically connected to a central controller 3230.

[0349] In one form, input device 3220 may be constructed or arranged to allow a person to select values ​​and / or menu options.

[0350] Central Controller

[0351] In one form of the present technology, the central controller 3230 is one or more processors adapted to control the RPT device 3000. The central controller 3230 is Figure 4C and Figure 4C-1 Shown in.

[0352] Suitable processors may include x86 Intel processors, -M processor, such as the STM32 series microcontroller from STMicroelectronics. In some alternative forms of the present technology, a 32-bit RISC CPU, such as the STR9 series microcontroller from STMicroelectronics, or a 16-bit RISC CPU, such as a processor from the MSP430 family of microcontrollers manufactured by Texas Instruments, may also be suitable.

[0353] In one form of the present technology, the central controller 3230 is a dedicated electronic circuit.

[0354] In one form, the central controller 3230 is an application specific integrated circuit. In another form, the central controller 3230 includes discrete electronic components.

[0355] The central controller 3230 may be configured to receive input signals from one or more transducers 3270 , one or more input devices 3220 , and / or the humidifier 4000 .

[0356] The central controller 3230 may be configured to provide output signals to one or more of the output device 3290 , the pressure generator 3140 , the therapy device controller 3240 , the data communication interface 3280 , and / or the humidifier 4000 .

[0357] In some forms of the present technology, the central controller 3230 is configured to implement one or more methods described herein, such as one or more algorithms 3300 that may be implemented with processor control instructions represented as a computer program stored in a non-transitory computer-readable storage medium, such as memory 3260. In some forms of the present technology, the central controller 3230 may be integrated with the RPT device 3000. However, in some forms of the present technology, some methods may be performed by a remotely located device. For example, the remotely located device may determine control settings for the ventilator or detect a breathing-related event by analyzing stored data, such as from any of the sensors described herein.

[0358] clock

[0359] The RPT device 3000 may include a clock 3232 connected to a central controller 3230 .

[0360] Therapy Device Controllers

[0361] In one form of the present technology, the therapy device controller 3240 is a therapy control module 3330 that forms part of the algorithm 3300 executed by the central controller 3230.

[0362] In one form of the present technology, the therapy device controller 3240 is a dedicated motor control integrated circuit. For example, in one form, the MC33035 brushless DC motor controller manufactured by ONSEMI is used.

[0363] Protection Circuit

[0364] One or more protection circuits 3250 in accordance with the present technology may include electrical protection circuits, temperature and / or pressure safety circuits.

[0365] Memory

[0366] According to one form of the present technology, the RPT device 3000 includes a memory 3260, such as a non-volatile memory. In some forms, the memory 3260 may include a battery powered static RAM. In some forms, the memory 3260 may include a volatile RAM.

[0367] Memory 3260 may be located on PCBA 3202. Memory 3260 may be in the form of EEPROM or NAND flash memory.

[0368] Additionally or alternatively, the RPT device 3000 includes memory 3260 in a removable form, such as a memory card made in accordance with the Secure Digital (SD) standard.

[0369] In one form of the present technology, the memory 3260 serves as a non-transitory computer-readable storage medium having stored thereon computer program instructions representing one or more of the methods described herein, such as one or more algorithms 3300 .

[0370] Data communication system

[0371] In one form of the present technology, a data communication interface 3280 is provided and connected to a central controller 3230 (see, for example, Figure 4C ). The data communication interface 3280 may be connected to a remote external communication network 3282 and / or a local external communication network 3284. The remote external communication network 3282 may be connected to a remote external device 3286. The local external communication network 3284 may be connected to a local external device 3288.

[0372] In one form, the data communications interface 3280 is part of the central controller 3230. In another form, the data communications interface 3280 is separate from the central controller 3230 and may include an integrated circuit or processor.

[0373] In one form, the remote external communication network 3282 is the Internet. The data communication interface 3280 may connect to the Internet using wired communication (eg, via Ethernet or fiber optics) or wireless protocols (eg, CDMA, GSM, LTE).

[0374] In one form, the local external communications network 3284 utilizes one or more communications standards, such as Bluetooth or consumer infrared protocols.

[0375] In one form, the remote external device 3286 is one or more computers, such as a cluster of networked computers. In one form, the remote external device 3286 can be a virtual computer, rather than a physical computer. In either case, this remote external device 3286 can be accessed by a properly authorized person (such as a clinician).

[0376] The local external device 3288 may be a personal computer, a mobile phone, a tablet or a remote control.

[0377] Output devices including optional display, alarm

[0378] Output devices 3290 according to the present technology may take the form of one or more of visual, audio, and tactile units. The visual display may be a liquid crystal display (LCD) or a light emitting diode (LED) display.

[0379] Display Driver

[0380] The display driver 3292 receives characters, symbols, or images for display on the display 3294 as input, and converts them into commands that cause the display 3294 to display the characters, symbols, or images.

[0381] monitor

[0382] The display 3294 is configured to visually display characters, symbols, or images in response to commands received from the display driver 3292. For example, the display 3294 may be an eight-segment display, in which case the display driver 3292 converts each character or symbol (such as the digit "0") into eight logic signals that indicate whether the eight corresponding segments are to be activated to display the particular character or symbol.

[0383] Air circuit

[0384] The air circuit 3170 according to one aspect of the present technology is a conduit or tube that is constructed and arranged to allow air flow to travel between two components (such as the RPT device 3000 and the patient interface 2000 or 2800) in use.

[0385] Specifically, the air circuit 3170 can be fluidly connected to the outlet of the pneumatic block 3020 and the patient interface. The air circuit can be referred to as an air delivery tube. In some cases, there can be separate branches of the circuit for inhalation and exhalation. In other cases, a single limb is used.

[0386] In some forms, the air circuit 3170 may include one or more heating elements configured to heat the air in the air circuit, for example to maintain or increase the temperature of the air. The heating element may be in the form of a heating wire loop and may include one or more transducers, such as a temperature sensor. In one form, the heating wire loop may be helically wound around the axis of the air circuit 3170. The heating element may communicate with a controller such as a central controller 3230. An example of an air circuit 3170 including a heating wire loop is described in U.S. Patent 8,733,349, which is incorporated herein by reference in its entirety.

[0387] humidifier

[0388] Humidifier Overview

[0389] In one form of the present technology, a humidifier 4000 (e.g., Figure 5A 4000) to change the absolute humidity of the air or gas delivered to the patient relative to the ambient air. Typically, the humidifier 4000 is used to increase the absolute humidity of the air flow and increase the temperature of the air flow (relative to the ambient air) before delivery to the patient's airway.

[0390] The humidifier 4000 may include a humidifier reservoir 4110, a humidifier inlet 4002 for receiving an air flow, and a humidifier outlet 4004 for delivering a humidified air flow. Figure 5A and Figure 5B As shown, the inlet and outlet of the humidifier reservoir 4110 can be respectively a humidifier inlet 4002 and a humidifier outlet 4004. The humidifier 4000 can also include a humidifier base 4006, which can be adapted to receive the humidifier reservoir 4110 and include a heating element 4240.

[0391] Humidifier parts

[0392] Water reservoir

[0393] According to one arrangement, the humidifier 4000 may include a water reservoir 4110 configured to hold or retain a volume of liquid (e.g., water) to be evaporated to humidify the air flow. The water reservoir 4110 may be configured to maintain a predetermined maximum water capacity to provide adequate humidification at least during a respiratory therapy session, such as a night's sleep. Typically, the reservoir 4110 is configured to hold several hundred milliliters of water, for example, 300 milliliters (ml), 325 ml, 350 ml, or 400 ml. In other forms, the humidifier 4000 may be configured to receive a water supply from an external water source, such as a building's water supply system.

[0394] According to one aspect, water reservoir 4110 is configured to add humidity to the air flow from RPT device 3000 as the air flow travels therethrough. In one form, water reservoir 4110 may be configured to encourage the air flow to travel in a tortuous path through reservoir 4110 while in contact with the volume of water therein.

[0395] According to one form, the reservoir 4110 may be arranged, for example, along Figure 5A and Figure 5B The sideways orientation is shown removed from the humidifier 4000.

[0396] The reservoir 4110 may also be configured to prevent liquid from flowing out of it, such as through any orifices and / or among its subcomponents, such as when the reservoir 4110 is displaced and / or rotated from its normal operating orientation. Since the air flow to be humidified by the humidifier 4000 is typically pressurized, the reservoir 4110 may also be configured to avoid loss of pneumatic pressure through leakage and / or flow resistance.

[0397] Conductive part

[0398] According to one arrangement, the reservoir 4110 includes a conductive portion 4120 that is configured to allow efficient transfer of heat from the heating element 4240 to the liquid content in the reservoir 4110. In one form, the conductive portion 4120 can be arranged as a plate, but other shapes are also suitable. All or a portion of the conductive portion 4120 can be made of a thermally conductive material such as aluminum (e.g., with a thickness of about 2 mm, such as 1 mm, 1.5 mm, 2.5 mm or 3 mm), another thermally conductive metal, or some plastics. In some cases, suitable thermal conductivity can be achieved with a material of appropriate geometry that has lower conductivity.

[0399] Humidifier reservoir base

[0400] In one form, the humidifier 4000 may include a humidifier reservoir base 4130 (eg, Figure 5B ), the humidifier reservoir base 4130 is configured to receive the humidifier reservoir 4110. In some arrangements, the humidifier reservoir base 4130 may include a locking feature, such as a locking rod 4135 configured to hold the reservoir 4110 in the humidifier reservoir base 4130.

[0401] Water level indicator

[0402] The humidifier reservoir 4110 may include FIG. 5A to FIG. 5B 4150. In some forms, the water level indicator 4150 can provide a user (such as the patient 1000 or a caregiver) with one or more indications regarding the volumetric amount of water in the humidifier reservoir 4110. The one or more indications provided by the water level indicator 4150 can include an indication of a maximum predetermined volume of water, any portion thereof (such as 25%, 50%, 75%), or a volume such as 200 ml, 300 ml, or 400 ml.

[0403] Respiratory waveform

[0404] Figure 6Figure 1 shows a typical breathing waveform of a model of a person sleeping. The horizontal axis is time, and the vertical axis is respiratory flow. Although the parameter values ​​can vary, a typical breath can have the following approximate values: tidal volume Vt 0.5L, inhalation time T i 1.6 seconds, peak inspiratory flow Q 峰 0.4L / sec, exhalation time T e 2.4 seconds, peak expiratory flow Q 峰 -0.5L / sec. Total duration of breathing T 总 About 4 seconds. People usually breathe at a rate of about 15 breaths per minute (BPM), and the ventilation volume Vent is about 7.5L / minute. The typical duty cycle T i With T 总 The ratio is about 40%.

[0405] Complementary therapies

[0406] In embodiments of the present technology, an airflow generated for a respiratory pressure therapy (e.g., CPAP) can also be used to provide a supplemental therapy. As described in more detail below, at least a portion of the airflow generated for the respiratory therapy can also be used for the supplemental therapy. In this regard, the supplemental therapy can be an airflow derived (e.g., offset) from an air pressure generator and configured to provide an alternative type of therapy, i.e., in addition to and different from the existing therapy provided (i.e., respiratory therapy).

[0407] refer to Figure 7 , shows an apparatus 5000 for utilizing an air flow generated by an air pressure generator (e.g., flow generator 5002) to direct air through a patient interface (e.g., a sealing structure (such as, for example, Figure 8B The full face mask 5006 shown) or a sealing structure (such as Fig. 8A The pressurized air conduit (e.g., tube 5004) of the nasal mask 5006 and headcuff tube 5012) is supplied to the patient. The mask 5006 (in any form) can be a seal-forming structure as previously described, which is configured to provide a seal around the patient's airway.

[0408] In one form of the technology, a supplemental flow device 5008 is at least partially disposed on the patient interface for adapting a portion of the gas flow from the flow generator 5002 for use as an active supplemental therapy or a passive supplemental therapy (as described in more detail below).

[0409] The patient interface, supplemental flow device, and / or flow generator 5002 may also be connected to a sensation monitoring and stimulation unit 5010. As described in more detail later, the sensation monitoring and stimulation unit 5010 may be implemented with a controller (not shown) to control how active and passive types of supplemental therapy are delivered to the patient.

[0410] As described above, in some forms, supplemental therapy may be active in nature, whereby a portion of the airflow from the supplemental flow device is configured to treat a breathing disorder, such as OSA. An example of active supplemental airflow may be positional therapy, where the airflow is deflected to stimulate the patient to change their sleeping position.

[0411] In other forms, supplemental therapy may be passive in nature, whereby supplemental airflow is configured to improve the patient's sleeping environment. The sleeping environment may include the air temperature of a location (e.g., the room in which the patient sleeps), ambient light, noise, air humidity, air pollutants (i.e., pollen, allergens, etc.), etc.

[0412] Thus, passive supplemental therapy may involve using offset airflow to move air around a patient (eg, by blowing air over the patient's skin) in order to cool the patient during sleep.

[0413] refer to Fig. 8A and Figure 8B , shows the apparatus 5000 in use, comprising a patient interface for delivering a supply of breathable gas via tube 5004 to an entrance to the airway of a patient. Fig. 8A In the embodiment, the patient interface includes a nasal pillow mask 5006 and a head sleeve 5012. Figure 8B In the embodiment, the patient interface includes a full face mask 5006. The patient interface (both forms) includes a supplemental flow device 5008 for delivering a supplemental flow of gas. In either case, the patient interface can be configured to deliver the supplemental therapy as an active or passive therapy.

[0414] Tube

[0415] The device 5000 may include a single tube 5004 extending between a flow generator 5002 and a mask 5006. As previously described, the tube 5004 may deliver the pressurized gas flow to the mask 5006 (eg, Figure 8B 5002). The pressurized airflow can be considered to be a primary airflow or mainstream, i.e., having a first portion of airflow for providing respiratory therapy and including a second portion that can be offset from the primary airflow for use in supplemental therapy. That is, the supplemental flow device can offset a secondary airflow, i.e., a second portion of the airflow, from the primary airflow generated by the flow generator 5002. The secondary airflow is directed away from the patient's airway.

[0416] In some forms, a supplemental flow device 5008 may be provided in the outer wall of the mask (i.e., the plenum chamber) for directing the airflow received from the tube to the patient. In this form, the supplemental flow device 5008 may deflect the airflow to the source of the airflow before it is delivered into the plenum chamber for: i) existing respiratory therapy; and ii) supplemental therapy.

[0417] As discussed in greater detail later, airflow may be deflected from a single tube 5004 through an airflow path. Figure 8B 5004. In the form of a single tube connected between the flow generator 5002 and the mask 5006, the airflow can be deflected into this path (from the tube 5004) before the airflow enters the plenum chamber of the full face mask 5006. That is, the airflow from the flow generator 5002 is deflected into the path before the airflow mixes with, for example, the patient's exhaled air contained in the mask 5006.

[0418] Advantageously, deflecting the airflow in this manner (i.e., avoiding mixing with the air in the mask) can help maintain lower air temperature and humidity in the air delivered for supplemental therapy. In other words, if the primary airflow (i.e., the airflow generated by the flow generator) enters the mask before being deflected into the secondary airflow (i.e., deflected into this path), the primary airflow will mix with the patient's exhaled air within the mask (i.e., the plenum) to warm and humidify the air before it is deflected into the secondary airflow.

[0419] In some forms of the device 5000, it may be preferred to warm and humidify the secondary airflow directed to the patient. In other forms, the secondary airflow may be preferably cooled, or maintained generally at ambient room temperature prior to contacting the patient's skin. As described in more detail later, the temperature and humidity of the secondary airflow (i.e., the airflow that contacts the patient's skin) may be selected depending on the type of complementary therapy being administered. For example, if the patient's body temperature is determined to be too high, the secondary airflow may be preferably cooled. Alternatively, if the ambient air temperature (i.e., around the patient) is determined to be low, the secondary airflow may be warmed in order to, for example, gently stimulate the patient to wake up, for example, at a predetermined time. In some forms, the secondary airflow is directed to the patient or its surroundings without any further conditioning.

[0420] In other forms, the device 5000 may include separate airflow sources, such as two, three, etc. For example, Figure 8C-1 and Figure 8C-2 As shown, two tubes 5004a, 5004b, 5005a, 5005b may be provided for delivering two separate gas streams to the patient interface. Figure 8C-1 In the form shown, a double branch tube can be provided for dividing the gas flow from a single tube 5004 into two separate gas flows for delivery to the patient. In this form of double branch tube, a single tube 5004 connected to a flow generator 5002 can be divided into branches 5004a, 5004a for directing the separate gas flows to the patient.

[0421] exist Figure 8C-2In the illustrated form, two separate tubes 5005a, 5005b are configured to extend between the flow generator 5002 and the patient interface, each tube having a separate airflow output generated by the flow generator 5002. In this form, each tube is separately connected to the flow generator so that the flow generator can be configured to generate, for example, airflows of different velocities and direct the airflows of different velocities to the mask via the separate tubes.

[0422] In this form, one of the tubes provided may be configured to deliver a prescribed therapeutic pressure to the patient. Another of the tubes may form part of or be adapted to be connected to a supplementary flow device 5008, whereby the device 5008 is configured to deliver a supplementary gas flow to the patient.

[0423] Advantageously, the individual airflows through each tube can be regulated differently. For example, the humidity, temperature, pressure, etc. can be different between the two tubes in order to provide different types of airflows to the patient. Figure 8C-1 In the case of a dual branch tube, one of the tubes can be provided with a heating element for heating the airflow delivered to the mask 5006, while the other of the tubes can be unheated in order to deliver a cooler (and drier) airflow for use in conjunction with complementary therapy.

[0424] In some forms of separate tubes (i.e. Figure 8C-2 ), each tube may be provided with a different airflow source, whereby the flow generator is configured to provide two corresponding independent airflow sources to the two tubes. For example, each airflow (delivered through each tube) may be supplied by a different motor. In this case, each motor may independently control the airflow through each tube. Advantageously, this may minimize the size of the electrical load placed on a single motor that supplies separate airflow sources to an existing respiratory therapy and a supplemental therapy.

[0425] In some forms, the two tubes can be configured as concentric tubes with an inner tube and an outer tube. In this form, the inner tube can be configured to deliver the primary gas flow to the patient interface (i.e., for respiratory therapy), and the outer tube can be configured to deliver a separate secondary gas flow for supplemental therapy. In this regard, the secondary flow can be a coherent flow (i.e., through the inner tube contained within the outer tube).

[0426] In either form, i.e., having a single tube 5004, two separate tubes or dual branch tubes 5004a, 5004b, 5005a, 5005b, or concentric tubes, the patient interface may also be provided with an airflow path (as previously described) for deflecting airflow from the tube as part of a supplemental flow device 5008. In some forms, the airflow path may include a channel formed in the frame of the mask, and in other forms, the airflow path may include a passageway formed in the conduit of a headcuff tube, wherein the tube forms part of the patient interface. In either form, the passageway is coupled between the tube and the supplemental flow device 5008.

[0427] refer to Figure 8B , path 5013 (i.e., channel) is indicated by a dotted line. In this figure, the dotted line represents an example of how the path can be configured, but it is conceivable that other configurations can also be used to guide airflow between tube 5004 and mask 5006.

[0428] refer to Fig. 8A , a similar channel 5012 may be formed in a conduit of, for example, a nasal mask, the channel 5012 being configured to direct the airflow from the tube to the supplemental flow device. Although the channel is indicated on one of the two conduits, i.e., lumen 5012 (indicated by dashed lines), it is contemplated that two channels may be provided (one on a respective side of the patient's face). In this form, the channel may provide a separate pathway for the airflow, i.e., separate from the airflow provided for respiratory therapy.

[0429] exist Fig. 8A and Figure 8B In either form of the channels 5012, 5013 shown, the channels can be pneumatically connected to a tube, i.e., for receiving air from the flow generator 5002. Figure 8C-1 and Figure 8C-2 , note that channels 5012, 5013 can also be configured to receive air from tubes 5004a or 5004b and 5005a or 5005b, depending on the type of tubes provided.

[0430] It should also be noted that although Figure 8C-1 and Figure 8C-2 Two tubes of equal size (i.e., equal diameter) are shown, but one of these tubes may have a different size. For example (and as described in more detail later), one of these two tubes may be configured (e.g., sized) to connect directly to channels 5012, 5013.

[0431] As described in more detail below, the supplemental flow device can be configured to control (ie, regulate) when and how supplemental therapy is administered. For example, when airflow is allowed to pass from the tube, through the device 5008; and which of active or passive therapy is provided.

[0432] Supplementary flow device

[0433] In any form of the tube, i.e., single branch, split or double branch, the supplemental flow device 5008 can be configured to provide active or passive therapy. In the case of active therapy, the airflow can be targeted by, for example, a nozzle so as to apply a flow of pressurized airflow toward the patient (e.g., applied to the patient's skin) for stimulating the patient (i.e., disturbing the patient) during sleep. Alternatively or additionally, the secondary airflow can be directed to a specific portion of the patient's airway. In this form, the secondary airflow delivered from the supplemental flow device can be directed into the mask 5006. This can be controlled based on the respiratory phase (e.g., during inhalation), directing the airflow to the nose and / or mouth, thereby inhaling newer, fresher air. During exhalation, the airflow can be directed to one or more locations of the patient interface to flush the accumulated carbon dioxide. In another form, the secondary airflow can be directed to a specific nostril to synchronize with the patient's nasal cycle.

[0434] Alternatively, for passive therapy, the airflow can be diffused, for example, by device 5008, so that the airflow contacts the patient's skin, i.e., the airflow is distributed over a larger skin area than the targeted airflow of active therapy. Advantageously, the diffused airflow can change the patient's sleeping environment, for example, by cooling the patient's skin, without disturbing their sleep.

[0435] The supplemental flow device 5008 can be in the form of a flow regulator valve 5014 for controlling airflow through the device 5008. For example, the valve can be operated to move between an open position and a closed position for controlling when airflow moves through the valve. As described in more detail later, airflow through the valve can be regulated to control, for example, flow through the device 5008. In this regard, the flow regulator can be used to control whether the airflow disturbs the patient's sleep.

[0436] In some forms, the supplemental flow device may be provided with a constant flow vent for delivering a substantially constant air flow toward the patient. The constant flow vent is configured to deliver a substantially constant air flow to the patient regardless of the air pressure output by the flow generator. This may be particularly relevant for, for example, an automatic setting device / flow generator, whereby the air pressure output to the patient for supplemental therapy may be affected by, for example, a variable airflow of the automatic setting device. Advantageously, the substantially constant air flow provided by the constant flow vent can provide a more comfortable (i.e., predictable) airflow on the patient's skin.

[0437] like Fig. 8A and Figure 8BAs shown, the supplemental flow device may include an array of orifices 5008 configured in the mask. The array of orifices (referred to herein as an "orifice array") may be arranged on opposite sides of the mask, i.e., so that the left and right sides of the patient may receive supplemental therapy.

[0438] Specifically refer to Fig. 8A The orifice may be arranged relative to the mask, i.e., located in a portion of the catheter tip cover, proximal to the cushion module (i.e., 5006).

[0439] Regardless of the type of patient interface (i.e., full face, nasal pillows, etc.), the location of the orifices can be positioned based on the targeted anatomical features. For example, in the case of active therapy, the array can be configured to direct air to typically sensitive areas of the skin, such as near the ears (e.g., Figure 8B ).

[0440] In some forms, ventilation (ie, a vent configured to allow flushing of exhaled gases) may also be used to deliver supplemental therapy. In other words, the orifice 5008 configured to deliver supplemental therapy may also be used to allow flushing of exhaled gases, such as carbon dioxide.

[0441] In some forms, the patient can control the airflow through the orifice 5008 according to their sensitivity to airflow. In this form, the orifice can be configured with a closure, whereby the patient can adjust the closure to adjust the size or number of the open orifices to control the airflow rate through the orifice. In some forms, the closure can be arranged to allow the patient to selectively close one or more orifices. For example, the patient can choose to close the orifices that direct air to undesirable locations on their face, while leaving some orifices open to direct air to more desirable locations.

[0442] Advantageously, the closure can allow the patient to customize (e.g., manually adjust) the supplemental therapy to suit their sensitivity. For example, some patients may be particularly sensitive to airflow on their skin. In this case, the patient can use the closure to reduce the airflow on their skin so that the airflow intended to cool the patient does not wake the patient.

[0443] The closure may be provided in various forms. For example, the closure may be a slidable plate that the patient may move across the apertures to open or close the air path through the apertures. In another example, an adhesive strip may be provided on the apertures to allow the patient to open and close the apertures by peeling off and re-adhering the adhesive strip on the apertures. In yet another example, one or more plugs may be provided for the patient to insert into the apertures or into a single opening leading to the apertures to block airflow therethrough.

[0444] In some forms, the closure may be provided as a fabric material configured to cover the aperture 5008 so as to block airflow therethrough. Fig. 8A In the form shown (where the aperture is located on the conduit), a fabric sleeve may be provided to cover the aperture 5008. In this regard, the fabric may be configured to completely block airflow, or may be configured to have a weave that allows airflow to diffuse therethrough.

[0445] In some forms, the fabric material may be configured as a type of diffuser material for distributing airflow over the patient's skin. In effect, the fabric material may prevent the airflow from being projected onto discrete locations of the patient's skin. This may have particular application in passive supplemental therapy, as will be described in more detail later, whereby the airflow is not intended to disturb / irritate the user during sleep.

[0446] In some forms, the array of orifices 5008 may be located at discrete locations along the length of the catheter (eg, Fig. 8A In the embodiment of the present invention, the orifice 5008 may be arranged in a manner such as that indicated by the reference numeral 5008d shown in the figure. In an alternative form, the array of orifices 5008 may be spaced apart, i.e. distributed along the length of the conduit, as indicated by the reference numeral 5008. In this form, the orifices may be dispersed over the length of the path / channel 5012 to guide the airflow from the channel. In other forms, the orifice may not be configured relative to the channel, in contrast, the orifice 5008 may be configured to guide the airflow from the conduit, i.e., for outputting the airflow of the conduit also used for respiratory therapy. As previously mentioned, the orifice of any form may also be configured to be a ventilator for flushing the exhaled gas.

[0447] In the form where the orifices 5008 are distributed over the channel, the orifices provide a "cooling" effect for the patient. These orifices can be arranged to face the patient, i.e., face the skin or be angled to direct the airflow to at least partially contact the skin. As described above, the orifices and conduits can be covered in a fabric sleeve for diffusing the airflow output from the orifices. Advantageously, the direction of the airflow towards the patient's skin can provide a cool sensation, i.e., a low temperature, to the patient during use. In fact, this can improve the comfort of the patient during respiratory therapy.

[0448] In some forms, the airflow can be directed within the seal-forming structure, i.e., at the anatomical features of the patient surrounded by the mask. In this form, the airflow (whether active or passive) can be directed to contact the patient's skin, or to direct the airflow toward the patient's airway.

[0449] The patient's skin enclosed by the mask can be targeted in the same manner as the patient's skin located outside the mask, ie, using active or passive airflow.

[0450] Advantageously, directing the airflow into the mask (i.e., into the seal-forming structure housed therein) maintains the positive airway pressure established by the flow generator. As will be described in greater detail later, deflecting the airflow from the mask may introduce additional pressure losses in the system, which may require a corresponding increase in power / output from the flow generator to compensate.

[0451] In other forms of supplemental flow devices, the supplemental airflow can be delivered as a controlled leak from a mask seal. For example, the mask seal can be a foam construction that provides discrete areas with intentional / controllable leakage through the foam structure / matrix.

[0452] In this form, the amount of leakage provided by, for example, a foam interface can be adjusted depending on the type of supplemental therapy provided. For example, a large amount of leakage through the interface can be used for active therapy, whereby the leakage disturbs the patient's sleep. Alternatively, a small amount of leakage can be used to cool the patient's skin.

[0453] Additionally, a leaky interface can be configured to leak within predictable and predetermined boundaries and physical locations, such as by changing airflow permeability or breathability near a patient's eye. In the case of a leaky foam interface, the material of the foam can be selected based on its permeability to help control the extent of leakage.

[0454] Reference now Fig. 9 , the supplemental flow device can be configured to deliver active and passive types of supplemental therapy. In the variation shown, a first array of apertures 5008a can be provided, for example, near the bridge of the nose and configured to direct airflow (i.e., active) onto the patient's face. A second array of apertures 5008b can be provided on the mask, which directs diffuse (i.e., passive) airflow onto the patient's face.

[0455] The array of apertures 5008a, 5008b can be in a replaceable component of the mask assembly (e.g., a cushion component). Advantageously, this places the apertures close to the patient's skin to ensure that the airflow directly contacts, for example, the skin, rather than inadvertently contacting, for example, the patient's eyes. In addition, providing the apertures on a replaceable component allows the position of the apertures to be adjusted according to the design of the replaceable component.

[0456] For example, in the case of a cushion, the location and arrangement of the orifices can be varied for each available size of cushion. That is, a large cushion can have orifices that are located lower relative to the bridge of the nose when compared to a cushion of a small size. In practice, this can ensure that the airflow from the orifices contacts generally the same area of ​​the patient's face.

[0457] In addition, providing an orifice on the replaceable component can allow the patient to use a cushion with an orifice 5008 (for supplemental therapy) or to use a cushion without an orifice (i.e., to choose not to perform supplemental therapy). In other words, some patients may prefer to use supplemental therapy and therefore may optionally apply a cushion that provides an orifice for their mask assembly.

[0458] Each of the aperture arrays 5008a, 5008b (i.e., for passive or active therapy) can be connected via a path (in Figure 8B 5008a).

[0459] As described above, the device 5008 in the form of a "passive / active switch" can also be used to adjust, for example, the pressure, speed, etc. of the airflow through any of the aperture arrays 5008a, 5008b. For example, the device can be partially opened to restrict airflow therethrough.

[0460] Flow Regulator

[0461] The system 5000 may include a flow regulator valve 5014 (referred to herein as "flow regulator 5014") for controlling at least a portion of the flow of gas through the device 5000. The flow regulator 5014 may be used to control the flow of gas through the channels / paths 5012, 5013 (as described above with respect to Fig. 8A and Figure 8B The invention also provides for passage of a therapeutic agent through the aperture array 5000c, as well as the aperture arrays 5008a, 5008b, 5008d, 5008s (ie, for passive or active therapy).

[0462] 10 to 15, the flow regulator 5014 may be configured to cause a portion of the breathing gas flow in the flow paths 5012, 5013 to flow from the head cannula 2350 (eg, Fig. 8A for nasal pillows) or tube 5004 (see Figure 8B , for example for full-face masks) offset.

[0463] The flow regulator 5014 may include a body 5016 having an inlet 5018 , an orifice array 5008 c , a blocking device 5024 , and first and second outlets 5020 a , 5020 b corresponding to respective first and second head sleeves 2350 .

[0464] The flow regulator 5014 may form a joint between the tube 5004 and the headcuff 2350. In other forms (not shown), the flow regulator 5014 may form a joint between the headcuff 2350 and an array of orifices of a device as previously described (e.g., orifice arrays 5000a and 5008b (i.e., in the cushion), 5008d and 5008s (i.e., along the length of the tube)). In some further forms, the flow regulator 5014 may form a joint between the tube 5004 and the mask, i.e., as Figure 8B The connection best shown is between the tube and the channel 5013 of the mask.

[0465] References Fig. 10A In the first form of the first embodiment shown, the orifice 5008c can be formed in the base 5022 of the body 5016. In the form shown, the flow regulator is contained within the head sleeve (i.e., the catheter). In this form, the orifice 5008c also extends through the head sleeve.

[0466] As previously described, tube 5004 can deliver the flow of breathing gas to a headcuff or mask (e.g., a full face mask). Although these orifices can deflect a portion of the breathing gas onto the patient, flow regulator 5014 is configured to deliver a majority of the flow of breathing gas to, for example, a nasal cushion, a full face mask, etc., for delivery of appropriate CPAP therapy.

[0467] like Fig. 10A As shown, when viewed from the front of the device, the orifice 5008c is oriented generally in the center of the base 5022 so as to be substantially aligned with the central region of the patient's head in use. The flow regulator 5014 can be arranged relative to the paths 5012, 5013 to connect between other orifices to control / regulate the flow therethrough, such as the flow at the orifice arrays 5000a, 5008b, 5008d, 5008s.

[0468] In a first embodiment, the blocking device 5024 is in the form of a wedge-shaped pendulum (referred to herein as "pendulum 5024"). The pendulum 5024 can be located in a chamber 5026 defined by the body 5016 and can be suspended at its apex 5028 so that the pendulum 5024 can pivot within the chamber (see FIG. Fig. 10B and Fig. 10C ).

[0469] In this embodiment, the pendulum 5024 is a gravity-driven component, whereby the pendulum 5024 can move under gravity. Fig. 10B The first configuration shown and Fig. 10C The second configuration shown.

[0470] like Fig. 10B and Fig. 10C As best shown in the side view of the body 5016, the orifice 5008c is positioned toward one side of the body 5016, i.e., offset from its central region. The orifice 5008c is positioned so that in use, when the positioning and stabilizing structure is worn by a patient, the orifice is positioned toward the patient's forehead (e.g., toward their frontal bone). In some forms (not shown), the flow regulator 5014 can be configured so that the orifice is positioned toward the back of the patient's head, such as toward their parietal bone. In this position, the orifice 5008c is aligned so that a portion of the flow of breathing gas is directed toward the patient.

[0471] The pendulum 5024 is configured so that when the patient is lying on his back (i.e., when his head is not tilted to one side), the pendulum 5024 moves, i.e., swings away from the orifice. This position of the pendulum (i.e., the resting position) is Fig. 10B , and allow air flow to pass through these openings so as to contact the patient, i.e. blow onto the patient.

[0472] When the orifice 5008c is open, breathing gas can flow therethrough, thereby "spraying" air at a high velocity onto the patient. In some forms of the flow regulator 5014, the spray can be used to disturb the patient's sleep because it is uncomfortable for the patient. In this form, the orifice can be positioned to directly contact the patient's skin. Advantageously, configuring these orifices to spray air onto, for example, the patient's forehead when they are placed on the patient's back can encourage the patient to move away from the supine position, i.e., to the side-lying position.

[0473] In some alternative forms of flow regulator 5014, the orifices may be arranged to direct the airflow onto the patient's hair. Advantageously, the patient's hair may act as a diffuser to diffuse the jet action of the airflow. This may produce a more "comfortable" (i.e., less intrusive) air flow onto the patient.

[0474] In some other forms, a diffuser may be used with the flow regulator 5014. The diffuser may be a mesh material positioned relative to the orifice so that the airflow passing therethrough is diffused. This may "weaken" the pressure of the airflow contacting the patient. Advantageously, this may be used to gently wake the patient, or alternatively, to cool the patient during sleep in order to improve their sleep.

[0475] The orientation of the patient's head can be determined by the side to which the patient's head is tilted. If the patient's head is tilted slightly or substantially toward its left or right side, the pendulum 5024 is configured to pivot toward the orifice 5008c. This position of the pendulum (i.e., the closed position) is as follows: Fig. 10C The pendulum in this position (ie, the forward position) blocks the passage of the air flow through the orifice 5008c so that the air flow no longer contacts the patient.

[0476] The wedge shape of the pendulum provides an offset mass that advantageously biases the pendulum into either a rest position (i.e., whereby the orifice is open) or a closed position (i.e., where the orifice is closed). In this regard, the pendulum can be considered "bistable," i.e., having more than one position in which it can be stable. The bistable characteristic means that the pendulum does not have one "stable" position that it moves toward / into.

[0477] Biasing the pendulum 5024 to either the rest position and the closed position can ensure that the pendulum 5024 does not move away from either the rest position and the closed position until the patient has completely changed sleeping positions, such as moving from a supine orientation to a side-lying orientation. In other words, the position of the pendulum can depend on the sleeping position of the patient.

[0478] Advantageously, the offset mass of the wedge shape can stabilize the pendulum 5024 during "slight" movements of the patient during sleep. Configuring the blocking device 5024 in this manner can also ensure that airflow is only allowed through these apertures once the pendulum 5024 is positioned away from the closed position, i.e., the patient is only disturbed when the patient has moved to the supine orientation.

[0479] Reference now Figures 11 to 13 , showing a second form of the first embodiment. In this form, the pendulum 5024 may include an array of corresponding orifices 5030 therein to allow for a passage through which airflow may pass. The pendulum 5024 in this form may be configured from a central position (e.g., Fig.11 and Fig. 12A ) moves (i.e. pivots) to a first configuration (as shown) Fig. 12B As shown) and a second configuration (as Fig. 12C shown).

[0480] The main difference between this second form of pendulum and the first form is that the second form pivots from "side to side" of the device in use, whereas the first form pivots from "front to back".

[0481] like Fig.11 and Fig. 12AAs shown, when the pendulum 5024 is in a centered configuration (i.e., positioned substantially in a central region of the chamber 5026), the orifice 5030 of the pendulum 5024 is aligned with the orifice 5008c of the body 5016. This alignment of the orifices 5030, 5008c allows breathing air (from the inlet 5018) to flow through the orifices 5030, 5008c to contact the patient.

[0482] Specific reference Fig. 12B , when the patient's head is oriented toward the first side, the pendulum 5024 is configured to move toward the first side of the patient by gravity. Conversely, if Fig. 12C As shown, when the patient's head is oriented toward the second side, the pendulum 5024 is configured to move toward the second side of the patient via gravity.

[0483] refer to Fig.11 and Fig. 12A In use, when the patient's head is not tilted toward the first side or the second side (for example when they are lying on their back), the pendulum 5024 is configured to be located in a central configuration, i.e., in a central region of the chamber 5026.

[0484] In this position, the orifices 5008c, 5030 of the base 5022 and the pendulum 5024 are aligned so that the flow of breathing gases is directed toward the patient.

[0485] Reference now Fig. 12B and Fig. 12C When the patient's head is oriented to one side, the pendulum 5024 can pivot to the first configuration or the second configuration so that the apertures 5008c, 5030 are no longer aligned. In effect, the pendulum 5024 blocks the passage of air flow through the apertures 5008c, 5030.

[0486] In this second form, the degree to which the pendulum 5024 is displaced from its central configuration can depend on the angle at which the patient's head is oriented toward the first side or the second side. Thus, the degree to which the respective orifices 5030, 5008c of each component are aligned can affect the magnitude of the air flow therethrough. That is, the proportion / magnitude of the flow of breathing gas through the orifices (and in contact with the patient) can be based on the orientation of the patient's head.

[0487] For example, when the patient is lying on their back, a slight movement of the patient's head to either side may cause the aperture 5008c to partially close. Advantageously, this can provide "positive reinforcement" to the patient, prompting their body to move into a side-lying orientation.

[0488] Reference now Fig.13In some forms of the device 5000, the flow regulator 5014 may form a junction connecting the tube 5004 and the pathways 5012, 5013 for connecting to the orifice arrays 5000a, 5008b, 5008d, 5008s. In this form, the flow regulator 5014 (including the pendulum 5024 and the orifice 5030) may be otherwise configured as previously described, i.e., whereby the pendulum does not include an orifice therein.

[0489] In this form, the path can extend through the base 5022 of the flow regulator 5014 and through, for example, the frame of the mask (e.g., Figure 8B 23) or through a conduit through headcuff 2350 (as previously described). In this regard, when pendulum 5024 is in a resting position or in a central configuration (i.e., when the patient is sleeping on their back), paths 5012, 5013 may be opened so that the flow of breathing gas is directed through the paths to orifice arrays 5000a, 5008b, 5008d, 5008s. When the patient's head is oriented to one side, pendulum 5024 may be pivoted to a closed position (as previously described). Fig. 10C ) or pivots to a first configuration or a second configuration (as shown Fig. 12B or Fig. 12C As shown), path channels 5012, 5013 are no longer open. Thus, these positions of the pendulum block the passage through which air flows.

[0490] Reference now FIG. 14A to FIG. 14C and FIG. 15A to FIG. 15C , a second embodiment of a flow regulator 6014 is shown. In the following description of the second embodiment, like reference numerals are used for like features with the prefix "6" added.

[0491] The second embodiment of the flow regulator 6014 differs from the first embodiment of the flow regulator 5014 primarily in that the blocking device 5024 is configured as a slider 5024. The slider 5024 may have a rectangular or square cross-sectional area and may be configured to slide between a first configuration and a second configuration, as described in detail below.

[0492] In the first form of the second embodiment, as FIG. 14A to FIG. 14C As shown, the slider 6024 may include an orifice 6030 configured to align with an orifice 6008c in the base 6022 of the flow regulator when the slider 6024 is in the center configuration. In the center configuration, the orifice 6030 of the slider is aligned with the orifice 6008c of the base to allow a passage for air flow therethrough.

[0493] The base 5022 may include stops 6032, and the slide 6024 may move between the stops 6032. Fig. 14B and Fig. 14C As shown, the slider 6024 can be configured to slide freely between the stops 6032. In this regard, weight can be added to the slider so that it can be a gravity-driven (i.e., slidable) component.

[0494] In use, when the patient's head is oriented toward one side, the slider 6024 can move away from the central configuration and enter any one of the first configuration and the second configuration. In the first configuration or the second configuration, the orifice 6030 is no longer aligned with the orifice 6008c, thereby blocking the passage through which the air flow passes.

[0495] In the second form, FIG. 15A to FIG. 15C As shown, the slide 6024 can include apertures 6030 configured to align with the paths 5012, 5013 in the base 6022 when the slide 6024 is in the centered configuration.

[0496] like Fig. 15B and Fig. 15C As shown, when the flow regulator 6014 is oriented toward one side, the slider 6024 can slide away from the central configuration and enter any one of the first configuration and the second configuration. In each of these configurations, the paths 5012, 5013 are closed, so that the passage through which the air flow passes is blocked.

[0497] As described in more detail later, the flow regulator 6014 may include sensors, actuators, and processing systems to determine when the air flow should be deflected to the orifice to contact the patient. In this form, the actuator may be configured to control the position of the slide so that it operates with power rather than gravity.

[0498] Sensory Monitoring and Stimulation Unit

[0499] The sensory monitoring and stimulation unit 5010 can be configured to determine when to operate passive and active therapies. That is, the unit 5010 can be connected to one or more sensors for measuring parameters of the surrounding environment or health metrics of the patient. These sensors can be located on or near the mask 5006 or flow generator 5002. In some forms, these sensors can be alternatively or additionally located on a portion of the tube 5004.

[0500] Sensors for detecting health metrics (i.e., physical condition) of a patient may measure, for example, heart rate, perspiration, temperature, respiratory rate, oxygen saturation, etc. Thus, sensors for detecting such parameters may include heart rate sensors, moisture sensors, thermistors, flow sensors, blood oximeters, etc.

[0501] Sensors configured to detect the ambient environment around the patient may measure, for example, ambient air temperature, humidity, pressure, etc. Information read by the sensors (for health metrics or ambient environment) may be recorded in real time (e.g., recorded in a memory of the RPT device) and may subsequently be called upon to preemptively adapt, for example, the patient's sleeping position or sleeping environment.

[0502] The sensation monitoring and stimulation unit 5010 may be integrated, i.e. connected to a controller (not shown) of the device 5000. The controller may be configured to control the operation of the flow generator 5002 based on input from the sensation monitoring and stimulation unit. The controller may be used, for example, to regulate the flow of the flow generator, to adjust the air pressure generated by the flow generator, etc.

[0503] In some forms, the supplemental flow device 5008 (e.g., when configured as a flow valve) can be adjusted by input from the sensory monitoring and stimulation unit 5010 to automatically adjust, for example, the flow rate during use. In this regard, the type of airflow directed to the patient (i.e., active or passive) can be adjusted based on changes (i.e., of the patient or the environment) occurring during sleep.

[0504] The sensory monitoring and stimulation unit 5010 may also be configured to determine, for example, whether the patient is sleeping, for example, in a supine position, and thereby activate the left or right side of the aperture array to, for example, cool the patient or warn the patient to change sleeping position. Advantageously, such selective activation of the aperture array may accommodate situations where the apertures may be blocked when, for example, a pillow or other object covers the array. Furthermore, this may be particularly advantageous for active therapy, as will be described in more detail later, whereby, for example, positional therapy, airflow is utilized to stimulate the patient to, for example, roll from a supine position to a side-lying position.

[0505] In some forms, the controller can be stored in the flow generator 5002 and connected to a visual display of the flow generator, such as a liquid crystal display (LCD). The display can allow the patient (or other user) to optionally adjust the settings of the complementary therapy, such as on / off, airflow rate in use, airflow pressure, airflow temperature, and airflow humidity, etc. Alternatively, the settings of the complementary therapy can be operated by a control device (not shown). The control device can be a smart phone, a computer, a stand-alone device, etc. In some forms, the control device can be configured to communicate wirelessly with the controller to allow the patient (or another user) to remotely control the operation of the complementary therapy.

[0506] Passive complementary therapy

[0507] As described above, passive supplemental therapy can be used to improve the patient's sleep environment. In some cases, changes in the patient's sleep environment (such as temperature, lighting, noise, etc.) can be associated with interruptions in the patient's sleep. Ultimately, this passive supplemental therapy aims to improve the patient's sleep health by actively influencing factors (such as sleep latency, sleep arousal, arousal, sleep efficiency, etc.).

[0508] Passive supplemental airflow can be used to actively influence these factors by changing the patient's sleeping environment without disturbing the patient's sleep. As previously mentioned, in some forms, if the patient's temperature rises during sleep, passive airflow can be directed to the patient's face to cool them down.

[0509] In this form, the airflow can be provided at ambient room temperature, whereby the movement of air across the patient's face is sufficient to reduce their body temperature. In other forms, the airflow delivered from the flow generator 5002 can be cooled to more effectively reduce the patient's temperature. For example, the airflow can be cooled by using a Peltier chip.

[0510] It should also be noted that, although airflow can be used to cool the patient, the airflow can be modified in other ways to improve the patient's sleep. For example, in the case where the patient's body temperature is reduced, the airflow can be warmed to warm the patient. In this regard, the heating element or tube 5004 of the humidifier (or in some cases, using the airflow from the plenum) can be used to warm the airflow delivered for passive therapy. In this regard, the temperature of the air can also be used for active therapy, i.e. stimulating the patient in sleep. For example, cool air can be delivered to warn the patient more effectively, i.e. rather than using ambient (i.e., warmer) temperature air.

[0511] In some forms, for example, the airflow directed into the channel can be configured to fit the headgear to the patient's face. For example, in the case of a catheter headgear, the airflow directed into the channel 5012 can be configured to change the shape and / or size of the channel 5012 so as to also change the shape and / or size of the headgear to more properly fit (i.e., conform to the patient's face) the patient's face. In this case, the flow generator can be configured with an algorithm to detect, for example, an unexpected leak from the mask, and thereby use the airflow directed into the channel 5012 to change the shape of the headgear so as to, for example, pull the mask 5006 tighter against the patient's face (until sealing contact with the patient's face).

[0512] In another example, the airflow directed into the channel 5012 can be configured to distribute the load applied by the headgear to, for example, a bony portion of the patient's face. In this case, the airflow can modify the headgear (e.g., deform the headgear) so that the headgear can have a wider contact area with the patient's skin. This may be particularly relevant to catheter headgear, but may also be used for headgear that does not include a catheter.

[0513] Now referring to other uses of passive airflow, passive airflow can actively affect the patient's sleep health by affecting the duration of sleep. That is, once the appropriate amount of sleep is reached, passive supplemental therapy can be used to wake up the patient. In this case, unlike providing an airflow that does not disturb the patient's sleep, the sensory monitoring and stimulation unit 5010 can be configured to apply a stimulating (i.e., more aggressive) type of airflow to wake the patient from sleep. In this regard, the airflow can be used as a type of "alarm clock", and the stimulating airflow can be intended to wake up the patient by directing the airflow to the sensitive parts of the patient's face.

[0514] It is noteworthy that the airflow can be used in this way to wake up the patient depending on the patient's sleep state. For example, the sensory monitoring and stimulation unit 5010 can be used to detect the patient's sleep state and then instruct the controller to supply airflow at specific time points during the sleep cycle to wake the patient at an ideal / optimal time point (e.g., during light sleep). Advantageously, determining the ideal time to alert the patient can avoid disturbing beneficial sleep states, such as deep sleep, REM sleep, etc.

[0515] The sensory monitoring and stimulation unit 5010 can be configured to automatically adjust how to deliver the supplemental therapy / airflow based on the information received from the sensor. It is also contemplated that the sensory monitoring and stimulation unit can be configured to collect information from online resources, such as weather (current or forecast), to assess the surrounding environment in which the patient will sleep. For example, air quality (e.g., pollen levels), temperature, humidity, etc. In turn, the sensory monitoring and stimulation unit can adjust, for example, the type, amplitude, etc. of the supplemental therapy provided to the patient during the duration of the patient's sleep.

[0516] The information received by the sensor can be used to cause the system to automatically adjust certain parameters of the supplemental therapy. For example, the measurement of ambient air temperature during the patient's sleep can cause the flow device 5008 and / or flow generator 5002 to modify operation in real time, such as by adjusting the size, temperature, etc. of the airflow.

[0517] In some forms, the sensory monitoring and stimulation unit 5010 can be configured to prompt the patient to manually adjust the delivery of the supplemental therapy. For example, if it is detected that the patient's body temperature is rising, the unit 5010 is configured to alert the user to adjust the supplemental therapy, such as by an audio alarm, a visual prompt on the device display, etc., to direct cool air onto the patient.

[0518] The sensory monitoring and stimulation unit 5010 may also be configured to receive information from sensors and / or from online resources to provide feedback to the patient about their sleep. For example, information about the patient's sleeping environment may be provided, for example, via a smart phone or other device connected to the Internet. Such feedback may inform the patient, for example, why their sleep is disturbed / interrupted.

[0519] Active complementary therapy

[0520] As previously mentioned, active supplemental therapy can be used to treat breathing disorders, such as OSA. As previously mentioned, in some forms, active airflow can be used for positional therapy to stimulate movement of the patient during an OSA event. In this case, the supplemental airflow can be configured to stimulate the patient to alert them to change their sleeping position, i.e., move to a side-lying position.

[0521] The sensory monitoring and stimulation unit 5010 can be configured to sense the patient's sleeping position and, based on the detected sleeping position, stimulate the patient to move from his or her sleeping position using airflow through the supplemental flow device 5008. This can be particularly useful for patients who are more likely to experience sleep apnea when, for example, they sleep on their backs. For example, in such a scenario when the patient is detected sleeping on his or her back, the unit 5010 can deliver airflow to stimulate the patient. The airflow is intended to prompt (i.e., induce) the patient to move to, for example, a side-lying position in order to reduce the chance of experiencing a sleep apnea event.

[0522] Advantageously, moving the patient off their back during sleep means that the flow generator can be operated at a lower pressure, i.e. because the patient's airway can be naturally open when the patient is lying on their back. In fact, the lower operating pressure means that the system is generally quieter (compared to when operating at a higher pressure), so the patient is less disturbed by, for example, noise and can therefore be more comfortable.

[0523] In some forms, the airflow delivered by the supplemental flow device 5008 can contact the patient's skin to stimulate the patient. The supplemental flow device can also be configured to direct air onto the patient's face, such as toward the patient's eyes, cheeks, chin, etc.

[0524] The location to which the airflow is directed and the pressure, velocity, etc. of the airflow can all be adjusted according to the desired stimulation magnitude. For example, different areas of the patient's face may be more or less sensitive to airflow, and thus the airflow can be directed to a specific location according to the type of response desired by the patient.

[0525] Traffic Generator

[0526] It is contemplated that respiratory pressure therapy (e.g., CPAP therapy) generally requires a higher airflow rate from the flow generator than is provided for passive or active supplemental therapy. Therefore, a flow generator configured for use with both respiratory and supplemental therapy may need to generate a higher output pressure than using respiratory pressure alone.

[0527] For example, a flow generator is needed to overcome additional pressure losses within the system. These losses may include losses as the airflow travels through one or more tubes, within the mask / duct, the ventilator, the supplemental flow device, and the connectors between them. The magnitude of the losses may also vary depending on many other parameters, including the geometry of the pneumatic path, etc.

[0528] Thus, the flow generator may, for example, be configured with a motor, power output, or the like that can maintain the therapeutic pressure required, for example, for CPAP, while additionally providing a source of supplemental airflow.

[0529] Additionally, the flow generator can be configured to identify supplemental gas flow as an "intentional leak" as distinct from an accidental leak. Advantageously, configuring the flow generator in this manner means that gas flow from supplemental therapy will not be detected / recorded as an accidental leak, thereby allowing the flow generator to operate with appropriate functionality (e.g., pressure, etc.).

[0530] Glossary

[0531] For purposes of this technology disclosure, in some forms of the technology, one or more of the following definitions may apply. In other forms of the technology, alternative definitions may apply.

[0532] generally

[0533] Air: In some forms of the present technology, air may be taken to mean atmospheric air, and in other forms of the present technology, air may be taken to mean some other combination of breathable gases, such as oxygen-enriched air.

[0534] Environment: In certain forms of the present technology, the term environment will be taken to mean (i) external to the treatment system or patient, and (ii) directly surrounding the treatment system or patient.

[0535] For example, relative to the environment of the humidifier humidityIt may be the humidity of the air directly surrounding the humidifier, such as the humidity in the room that the patient is sleeping in. Such ambient humidity may be different from the humidity outside the room where the patient is sleeping.

[0536] In another example, ambient pressure may be the pressure immediately surrounding or external to the body.

[0537] In some forms, ambient (e.g., acoustic) noise may be considered to be the background noise level in the room the patient is in, rather than, for example, noise generated by the RPT device or emanating from a mask or patient interface. Ambient noise may be generated by sources outside the room.

[0538] Automatic Positive Airway Pressure (APAP) Therapy: CPAP therapy in which the treatment pressure is automatically adjusted (eg, varies with each breath) between a minimum and a maximum limit, depending on whether there is an indication of an SDB event.

[0539] Continuous Positive Airway Pressure (CPAP) Therapy: A respiratory pressure therapy in which the treatment pressure is approximately constant throughout the patient's breathing cycle. In some forms, the pressure at the airway entrance is slightly higher during exhalation and slightly lower during inspiration. In some forms, the pressure will vary between different breathing cycles of the patient, for example increasing in response to detecting an indication of partial upper airway obstruction and decreasing in the absence of an indication of partial upper airway obstruction.

[0540] Flow rate: The volume (or mass) of air delivered per unit time. Flow rate may refer to an instantaneous quantity. In some cases, references to flow rate will be to a scalar quantity, i.e. a quantity having only magnitude. In other cases, references to flow rate will be to a vector quantity, i.e. a quantity having both magnitude and direction. Flow rate may be given by the symbol Q. "Flow rate" is sometimes simply abbreviated to "flow" or "airflow".

[0541] In the example of a patient breathing, the flow may be nominally positive for the inspiratory portion of the patient's breathing cycle, and therefore negative for the expiratory portion of the patient's breathing cycle. The device flow Qd is the flow of air leaving the RPT device. The total flow Qt is the flow of air and any supplemental gas that reaches the patient interface via the air circuit. The ventilation flow Qv is the flow of air leaving the vent to allow flushing of exhaled gases. The leakage flow Ql is the leakage flow from the patient interface system or elsewhere. The respiratory flow Qr is the flow of air received into the patient's respiratory system.

[0542] Flow Therapy: Respiratory therapy that involves delivering a flow of air to the entrance of the airway at a controlled flow rate, called the therapy flow, which is usually positive throughout the patient's respiratory cycle.

[0543] Humidifier: The term humidifier will be taken to mean a humidifying device constructed and arranged or configured with a physical structure to be able to provide a therapeutically beneficial amount of water (H2O) vapor to an air flow to relieve a patient's medical respiratory condition.

[0544] Leakage: The term leakage is to be considered as unintended air flow. In one example, a leak may occur due to an incomplete seal between the mask and the patient's face. In another example, a leak may occur in the swivel elbow leading to the ambient environment.

[0545] Conducted noise (acoustics): Conducted noise in this document refers to the noise transmitted to the patient through the pneumatic path (such as the air circuit and patient interface and the air therein). In one form, conducted noise can be quantified by measuring the sound pressure level at the end of the air circuit.

[0546] Radiated noise (acoustics): Radiated noise in this document refers to the noise transmitted to the patient by the ambient air. In one form, radiated noise can be quantified according to ISO 3744 by measuring the sound power / sound pressure level of the object in question.

[0547] Ventilation noise (acoustic): Ventilation noise in this document refers to the noise generated by the flow of air through any vent, such as the vent holes of a patient interface.

[0548] Oxygen-enriched air: air having an oxygen concentration greater than that of atmospheric air (21%), such as at least about 50% oxygen, at least about 60% oxygen, at least about 70% oxygen, at least about 80% oxygen, at least about 90% oxygen, at least about 95% oxygen, at least about 98% oxygen, or at least about 99% oxygen. "Oxygen-enriched air" is sometimes referred to simply as "oxygen."

[0549] Medical oxygen: Medical oxygen is defined as oxygen-enriched air with an oxygen concentration of 80% or greater.

[0550] Patient: A person, whether or not they have a respiratory condition.

[0551] Pressure: Force per unit area. Pressure can be expressed in a range of units, including cmH2O, gf / cm 2 , hectopascal. 1cmH2O is equal to 1g-f / cm 2 And about 0.98 hPa (1 hPa = 100 Pa = 100 N / m 2 =1 mbar to 0.001 atm). In this specification, unless otherwise stated, pressure is given in cmH2O.

[0552] The pressure in the patient interface is given the symbol Pm, while the treatment pressure is given the symbol Pt, which represents the target value to be achieved by the interface pressure Pm at the current moment.

[0553] Respiratory Pressure Therapy: The application of a supply of air to the entrance of the airways at a therapeutic pressure that is usually positive relative to atmosphere.

[0554] Ventilator: A mechanical device that provides pressure support to a patient to perform some or all of the work of breathing.

[0555] Materials and their properties

[0556] Silicone or Silicone Elastomer: Synthetic rubber. In this specification, reference to silicone is a reference to liquid silicone rubber (LSR) or compression molded silicone rubber (CMSR). One form of commercially available LSR is SILASTIC manufactured by Dow Corning (included in the range of products sold under this trademark). Another manufacturer of LSR is Wacker. Unless otherwise specified to the contrary, exemplary forms of LSR have a Shore A (or Type A) indentation hardness ranging from about 35 to about 45 as measured using ASTM D2240.

[0557] Polycarbonate: A thermoplastic polymer of bisphenol-A carbonate.

[0558] Mechanics

[0559] axis:

[0560] a. Circumferential axis: An axis oriented perpendicularly with respect to the longitudinal axis. This axis may be present in particular in pipes, tubes, cylinders or similar shapes with a circular and / or elliptical cross section.

[0561] Elasticity: The ability of a material to return to its original geometry after being deformed.

[0562] Resilience: The ability of a material to absorb energy when elastically deformed and release that energy when unloaded.

[0563] Elastic: Will release substantially all of its energy when unloaded. Includes, for example, some silicones and thermoplastic elastomers.

[0564] Rigid structure or component: A structure or component that does not substantially change shape when subjected to loads normally encountered in use. An example of such a use would be establishing and maintaining a sealing relationship of a patient interface with an entrance to a patient's airway, for example, under a load of approximately 20 to 30 cmH2O pressure.

[0565] For example, an I-beam may include a different bending stiffness (resistance to bending loads) in a first direction compared to a second orthogonal direction. In another example, a structure or component may be flexible in a first direction and rigid in a second direction.

[0566] Stiffness (or rigidity) of a structure or component: The ability of a structure or component to resist deformation in response to an applied load. The load can be a force or a moment, such as compression, tension, bending, or torsion. A structure or component may offer different resistance in different directions. The antonym of stiffness is compliance.

[0567] Structural elements

[0568] Elbow: An elbow is an example of a structure that directs the axis of an air flow traveling therethrough to change direction through an angle. In one form, the angle may be approximately 90 degrees. In another form, the angle may be greater than or less than 90 degrees. The elbow may have a cross-section that is approximately circular. In another form, the elbow may have an oval or rectangular cross-section. In some forms, the elbow may be rotated relative to a mating component, such as approximately 360 degrees. In some forms, the elbow may be removable from a mating component, such as via a snap connection. In some forms, the elbow may be assembled to a mating component via a disposable snap during manufacturing, but may not be removed by the patient.

[0569] Frame: A frame will be considered to mean the mask structure that carries the tensile load between two or more connection points to the headgear. A mask frame may be a non-airtight load-bearing structure in the mask. However, some forms of mask frames may also be airtight.

[0570] Tie (noun): A structure designed to resist tension.

[0571] Seal: can be a noun form referring to structure ("seal"), or a verb form referring to effect ("seal"). Two elements can be constructed and / or arranged to 'seal' or achieve a 'seal' therebetween without requiring a separate 'seal' element itself.

[0572] Swivel (n): A subassembly of components configured to rotate preferably independently about a common axis, preferably under low torque. In one form, the swivel may be configured to rotate through an angle of at least 360 degrees. In another form, the swivel may be configured to rotate through an angle of less than 360 degrees. When used in the context of an air delivery conduit, the subassembly of components preferably comprises a pair of matching cylindrical conduits. In use, little or no air flow leaks from the swivel.

[0573] Respiratory cycle

[0574] Apnea: According to some definitions, an apnea is considered to have occurred when the flow rate drops below a predetermined threshold for a sustained period of time (e.g., 10 seconds). An obstructive apnea is considered to have occurred when some obstruction of the airway does not allow air to flow despite the patient's efforts. A central apnea is considered to have occurred when an apnea is detected due to a decrease or absence of respiratory effort despite a patent airway. A mixed apnea is considered to have occurred when a decrease or absence of respiratory effort occurs simultaneously with an airway obstruction.

[0575] Respiratory Rate: The rate at which a patient breathes spontaneously, usually measured in breaths per minute.

[0576] Duty cycle: Inhalation time T i Total breathing time T 总 ratio.

[0577] Effort (of breathing): The work done by a spontaneously breathing person in an attempt to breathe.

[0578] Expiratory portion of the respiratory cycle: the period from the start of expiratory flow to the start of inspiratory flow.

[0579] Hypopnea: According to some definitions, hypopnea is considered a decrease in flow rather than an interruption in flow. In one form, hypopnea is considered to occur when flow decreases below a threshold rate for a sustained period of time. Central hypopnea is considered to occur when hypopnea is detected due to a decrease in respiratory effort. In one form in adults, any of the following may be considered hypopnea:

[0580] (i) The patient experiences a 30% decrease in respiration for at least 10 seconds, with an associated 4% desaturation; or

[0581] (ii) The patient's breathing decreases (but less than 50%) for at least 10 seconds with associated desaturations or arousals of at least 3%.

[0582] Hyperpnea: Increased air flow to above normal levels.

[0583] Inspiratory portion of the respiratory cycle: The period from the start of inspiratory flow to the start of expiratory flow is considered the inspiratory portion of the respiratory cycle.

[0584] Respiratory flow, patient airflow, respiratory airflow (Qr): These terms can be understood to refer to the RPT device's estimate of respiratory flow, as opposed to "true respiratory flow", which is the actual respiratory flow experienced by the patient, usually expressed in liters per minute.

[0585] Tidal volume (Vt): The volume of air inhaled or exhaled during normal breathing when no additional effort is exerted. In principle, the inspiratory volume Vi (the amount of air inhaled) is equal to the expiratory volume Ve (the amount of air exhaled), and thus a single tidal volume Vt can be defined to be equal to either amount. In practice, the tidal volume Vt is estimated as some combination of the inspiratory volume Vi and the expiratory volume Ve, such as an average value.

[0586] Inspiratory time (Ti): The duration of the inspiratory portion of the respiratory flow waveform.

[0587] Exhalation time (Te): The duration of the exhalation portion of the respiratory flow waveform.

[0588] Total time (T 总 ): The total duration between the start of one inspiratory portion of the respiratory flow waveform and the start of the next inspiratory portion of the respiratory flow waveform.

[0589] Upper airway obstruction (UAO): includes partial and complete upper airway obstruction. This may be associated with a state of flow limitation, where flow increases only slightly, or even decreases, with increasing pressure differential across the upper airway (Starling resistor behaviour).

[0590] Ventilation (Vent): A measure of the total amount of gas exchanged by a patient's respiratory system. Measurements of ventilation may include one or both of inspiratory flow and expiratory flow (per unit time). When expressed as volume per minute, this quantity is often referred to as "minute ventilation". Minute ventilation is sometimes given simply as volume, and is understood to be the volume per minute.

[0591] Ventilation

[0592] Expiratory Positive Airway Pressure (EPAP): The base pressure to which intra-breath varying pressures are added to produce the desired interface pressure that the ventilator will attempt to achieve at a given time.

[0593] Inspiratory Positive Airway Pressure (IPAP): The maximum desired interface pressure that the ventilator will attempt to achieve during the inspiratory portion of a breath.

[0594] Pressure Support: A number that indicates the increase in pressure during ventilator inspiration over the pressure during ventilator expiration, and usually means the difference in pressure between the maximum during inspiration and the base pressure (e.g., PS = IPAP - EPAP). In some cases, pressure support means the difference that the ventilator aims to achieve, rather than the difference that is actually achieved.

[0595] anatomy

[0596] Facial anatomy

[0597] Ala: The outer lining or "wing" of each nostril (plural: alar)

[0598] Alar angle: The angle formed between the wings of each nostril.

[0599] Alar tip: The outermost point on the wing of the nose.

[0600] Alar curvature (or alar ridge) point: The posteriormost point in the base line of curvature of each ala, found in the crease formed where the ala joins the cheek.

[0601] Auricle: The entire external visible part of the ear.

[0602] (Nose) Bony framework: The bony framework of the nose includes the nasal bones, the frontal process of the maxilla, and the nasal portion of the frontal bone.

[0603] (Nose) Cartilage framework: The cartilage framework of the nose includes the septal cartilage, lateral cartilage, major cartilage and minor cartilage.

[0604] Columella: The strip of skin that separates the nostrils and extends from the nasal prominence to the upper lip.

[0605] Columellar angle: The angle between a line drawn through the midpoint of the nostril cavity and a line drawn perpendicular to the Frankfort plane (where both lines intersect at the lower point of the nasal septum).

[0606] Frankfurt horizontal plane: A line extending from the lowest point of the orbital rim to the left tragus point. The tragus point is the deepest point in the notch above the tragus of the auricle.

[0607] Glabella: The most prominent point on the forehead in the midsagittal plane located on the soft tissue.

[0608] External nasal cartilage: A cartilaginous plate that is essentially triangular in shape. Its upper edge is attached to the nasal bone and the frontal process of the maxilla, and its lower edge is connected to the greater alar cartilage.

[0609] Sublabial (lower lip margin point): The lip extending between the lower point of the nasal septum and the mouth.

[0610] Supralip (upper lip point): The lip extending between the mouth and the supramental muscle.

[0611] Greater alar cartilage: A cartilaginous plate located beneath the lateral nasal cartilage. It curves around the front part of the nostril. Its posterior end is connected to the frontal process of the maxilla by a tough fibrous membrane that contains three or four minor cartilages of the alar nose.

[0612] Nares / Nostrils: The roughly oval-shaped openings that form the entrance to the nasal cavity. The singular form of nostrils (nares) is naris (nostril). The nostrils are separated by the nasal septum.

[0613] Nasolabial Folds or Nasolabial Folds: Folds or grooves of skin that extend from each side of the nose to the corners of the mouth, separating the cheeks from the upper lip.

[0614] Nasolabial angle: the angle between the columella and the upper lip (which intersect at the lower point of the nasal septum).

[0615] Auricular base: the lowest point where the auricle attaches to the facial skin.

[0616] Auricular base: the highest point where the auricle attaches to the facial skin.

[0617] Nasal prominence: The most prominent point or tip of the nose which can be identified in lateral view of the rest of the head.

[0618] Philtrum: The midline groove extending from the lower border of the nasal septum to the top of the lip in the upper lip area.

[0619] Mental point: located on the soft tissue, the most anterior midpoint of the chin.

[0620] Ridge (nose): The nasal ridge is the midline protuberance of the nose, extending from the nasal bridge point to the nasal protuberance point.

[0621] Sagittal plane: A vertical plane running from anterior (front) to posterior (back). The midsagittal plane is the sagittal plane that divides the body into left and right halves.

[0622] Nasal point: The most concave point on the soft tissue covering the frontonasal suture area.

[0623] Septal Cartilage (Nose): The septal cartilage forms part of the septum and separates the front part of the nasal cavity.

[0624] Alar nasalis: The point at the lower edge of the ala base where it joins the skin of the upper (upper) lip.

[0625] Subnasal point: The point on the soft tissue where the columella meets the upper lip in the midsagittal plane.

[0626] Supramental point: The point on the midline of the lower lip with maximum concavity between the midpoint of the lower lip and the soft tissue premental point.

[0627] Skull anatomy

[0628] Frontal Bone: The frontal bone includes a large vertical portion (the squama) that corresponds to the area called the forehead.

[0629] Mandible: The mandible forms the lower jaw. The mental protuberance is the bony protuberance of the lower jaw that forms the chin.

[0630] Maxilla: The maxilla forms the upper jaw and lies above the mandible and below the eye sockets. The frontal process of the maxilla projects upward from one side of the nose and forms part of the lateral border.

[0631] Nasal Bones: The nasal bones are two small oval bones that vary in size and form in different individuals; they lie side by side in the middle and upper parts of the face and form the "bridge" of the nose at their intersection.

[0632] Nasal root: The intersection of the frontal bone and the two nasal bones, the concave area directly between the eyes and above the bridge of the nose.

[0633] Occipital Bone: The occipital bone is located at the dorsal and lower part of the skull. It contains an oval hole (foramen magnum) through which the cranial cavity communicates with the vertebral canal. The curved plate behind the foramen magnum is the squama occipitalis.

[0634] Orbit: The bony cavity in the skull that holds the eyeball.

[0635] Parietal bones: The parietal bones are the bones that when joined together form the roof and sides of the skull.

[0636] Temporal bones: The temporal bones are located at the base and sides of the skull and support the part of the face called the temples.

[0637] Zygomatic bones: The face includes two zygomatic bones, which are located in the upper and outer parts of the face and form the prominence of the cheeks.

[0638] Respiratory system anatomy

[0639] Diaphragm: A sheet of muscle that runs across the base of the rib cage. The diaphragm separates the chest cavity, which contains the heart, lungs, and ribs, from the abdominal cavity. As the diaphragm contracts, the volume of the chest cavity increases and air is drawn into the lungs.

[0640] Larynx: The larynx or voice box houses the vocal cords and connects the lower part of the pharynx (hypopharynx) to the trachea.

[0641] Lung: The respiratory organ of humans. The conducting zone of the lungs contains the trachea, bronchi, bronchioles, and terminal bronchioles. The respiratory zone contains the respiratory bronchioles, alveolar ducts, and alveoli.

[0642] Nasal Cavity: The nasal cavity (or nasal fossa) is a large air-filled space above and behind the nose in the middle of the face. The nasal cavity is divided into two parts by a vertical wing called the nasal septum. On either side of the nasal cavity are three horizontal branches called the nasal conchae (singular "concha") or turbinates. The front of the nasal cavity is the nose, while the back joins into the nasopharynx via the choanae.

[0643] Pharynx: The part of the throat located just below (under) the nasal cavity and above the esophagus and larynx. The pharynx is conventionally divided into three sections: the nasopharynx (epipharynx) (the nasal part of the pharynx), the oropharynx (mesopharynx) (the oral part of the pharynx), and the hypopharynx (hypopharynx).

[0644] Patient Interface

[0645] Anti-Asphyxia Valve (AAV): A component or subassembly of a mask system that reduces the risk of the patient rebreathing too much CO2 by opening to the atmosphere in a safe manner.

[0646] Headgear: Headgear will be taken to mean a form of positioning and stabilising structure designed to hold a device (eg a mask) on the head.

[0647] Plenum: A mask plenum will be taken to mean a portion of the patient interface having walls at least partially enclosing a volume of space which, in use, has air pressurized to above atmospheric pressure therein. The shell may form part of the wall of the mask plenum.

[0648] Seal: can be a noun form referring to structure ("seal"), or a verb form referring to effect ("seal"). Two elements can be constructed and / or arranged to 'seal' or achieve a 'seal' therebetween without requiring a separate 'seal' element itself.

[0649] Vent: (noun): A structure that allows air to flow from the interior or conduit of a mask to ambient air for clinically effective flushing of exhaled gases. For example, clinically effective flushing may involve a flow rate of about 10 liters per minute to about 100 liters per minute, depending on the mask design and the therapy pressure.

[0650] The shape of the structure

[0651] Products according to the present technology may include one or more three-dimensional mechanical structures, such as a mask cushion or an impeller. The three-dimensional structure may be defined by two-dimensional surfaces. These surfaces may be distinguished using markings to describe the relative surface orientation, position, function, or some other feature. For example, a structure may include one or more of a front surface, a rear surface, an inner surface, and an outer surface. In another example, a seal-forming structure may include a face-contacting (e.g., outer) surface and a separate non-face-contacting (e.g., underside or inner) surface. In another example, a structure may include a first surface and a second surface.

[0652] Other Notes

[0653] A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent Office file or records, but otherwise reserves all copyright rights whatsoever.

[0654] Unless the context clearly indicates and a numerical range is provided, it is understood that each intervening value between the upper and lower limits of that range, to the tenth of the unit of the lower limit, and any other stated or intervening value in that stated range is encompassed within the technology. The upper and lower limits of these intermediate ranges may independently be included in the intermediate ranges and are also encompassed within the technology, subject to any specifically excluded limits in the stated range. Where the stated range includes one or both limits, ranges excluding either or both of those included limits are also included in the technology.

[0655] Furthermore, where a value or values ​​are described herein for implementation as part of the present technology, it should be understood that such values ​​may be approximate unless otherwise stated and that such values ​​may be used with any suitable significant figures to the extent that practical technical implementation may allow or require it.

[0656] Furthermore, "approximately," "substantially," "about" or any similar term as used herein means + / - 5% to 10% of the stated value.

[0657] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present technology, a limited number of exemplary methods and materials are described herein.

[0658] When a specific material is identified as being used to construct a component, obvious alternative materials having similar properties may be used as substitutes. In addition, unless otherwise specified, any and all components described herein are understood to be capable of being manufactured and thus may be manufactured together or separately.

[0659] It must be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural equivalents unless the context clearly dictates otherwise.

[0660] All publications mentioned herein are incorporated herein by reference in their entirety, to disclose and describe methods and / or materials as the subject of those publications. Publications discussed herein are provided solely for their disclosures prior to the filing date of the present application. This article should not be construed as admitting that the present technology is not entitled to be earlier than such disclosures due to prior inventions. In addition, the publication date provided may be different from the actual publication date, which may require independent confirmation.

[0661] The terms “comprises” and “comprising” should be understood to refer to elements, components or steps in a non-exclusive manner, indicating that the mentioned elements, components or steps may be present or utilized or combined with other elements, components or steps not explicitly mentioned.

[0662] The subject headings used in the detailed description are for the convenience of the reader's reference only and should not be used to limit the subject matter that can be found in the disclosure or claims as a whole. The subject headings should not be used to interpret the scope of the claims or claim limitations.

[0663] Although the technology herein has been described with reference to specific examples, it should be understood that these examples only illustrate the principles and applications of the present technology. In some cases, the terms and symbols may imply specific details that are not required for practicing the present technology. For example, although the terms "first" and "second" may be used, unless otherwise specified, they are not intended to indicate any order, but can be used to distinguish different elements. In addition, although the process steps in the method can be described or illustrated in order, such order is not necessary. Those skilled in the art will recognize that such order can be modified and / or various aspects thereof can be performed simultaneously or even synchronously.

[0664] It is therefore to be understood that numerous modifications may be made to the illustrative examples and that other arrangements may be devised without departing from the spirit and scope of the present technology.

[0665] Reference numerals list

[0666]

[0667]

[0668]

[0669]

Claims

1. An apparatus for delivering pressurized air or breathable gas to a patient, the apparatus comprising: a flow generator configured to generate an air flow; a patient interface constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the patient interface configured to deliver the pressurized air or breathable gas to the patient's airway for respiratory therapy; as well as an air delivery tube coupled between the flow generator and the patient interface to deliver a first portion of the flow of air from the flow generator to the patient interface as the pressurized air or breathable gas; as well as A supplemental flow device is configured to deliver a second portion of the flow of air to the patient as a supplemental activity of the respiratory therapy.

2. The apparatus of claim 1, wherein the second portion of the air flow is delivered away from the patient's airway.

3. The apparatus of claim 2, wherein the supplemental flow device is configured to deliver the second portion of the air flow to an exterior of the patient interface.

4. The apparatus of claim 2, wherein the supplemental flow device is configured to deliver the second portion of the air flow to the patient's skin.

5. An apparatus according to claim 4, wherein the supplemental flow device is configured to target discrete locations of the patient's skin with the second portion of the air flow to stimulate a response in the patient, the response forming at least part of an active supplemental therapy.

6. The apparatus of claim 4, wherein the supplemental flow device is configured to diffuse the second portion of the air flow over the patient's skin to change the environment around the patient.

7. The apparatus of claim 1, wherein the second portion of the air flow is directed to one or more specific areas of the patient's airway as the supplemental activity.

8. An apparatus according to claim 1, wherein the patient interface comprises a frame configured to conform to the shape of the patient's face, and the supplemental flow device forms a part of the patient interface and is arranged in the frame to direct the second portion of the air flow as part of the supplemental therapy.

9. The apparatus of claim 8, wherein the supplemental flow device comprises a path for directing the second portion of the air flow, the path being at least partially disposed on the frame of the patient interface.

10. The apparatus of claim 1, comprising more than one supplemental flow device for directing the second portion of the air flow toward more than one location.

11. An apparatus according to claim 10, wherein the more than one supplemental flow devices are used to deliver more than one active supplemental therapy and / or passive supplemental therapy to the patient, in which the active supplemental therapy is configured to stimulate a response in the patient's body and in which the passive supplemental therapy is configured to change the environment around the patient.

12. The apparatus of claim 1, wherein the supplemental flow device comprises an array of orifices configured to direct the air flow.

13. The device according to any one of claims 1 to 12, further comprising a flow regulator valve for regulating the second portion of the air flow flowing to the patient, the flow regulator being configured to move between an open state allowing air flow through the flow regulator and a closed state blocking air flow through the flow regulator, wherein the state of the flow regulator valve between the open state and the closed state depends on the orientation of the device.

14. Apparatus according to claim 13, wherein the flow regulator valve is arranged to move between the closed state and the open state under the action of gravity.

15. A patient interface for delivering pressurized air or breathable gas to a patient, the patient interface being constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway to deliver the pressurized air or breathable gas to the patient's airway for respiratory therapy, the patient interface also comprising a supplemental flow device configured to offset at least a portion of the pressurized air or breathable gas as a supplemental activity for the respiratory therapy.

16. A patient interface according to claim 13, wherein the supplemental flow device is configured to divert at least a portion of the pressurized air or breathable gas away from the airway of the patient.

17. A patient interface according to claim 12, wherein the supplemental flow device is configured to deliver the deflected pressurized air or breathable gas to the patient's skin outside of the patient interface.

18. A patient interface according to claim 15, wherein the supplemental flow device is configured to target discrete locations of the patient's skin with a deflected air flow to stimulate a response in the patient, the response forming at least a part of an active supplemental therapy.

19. A patient interface according to claim 15, wherein the supplemental flow device is configured to diffuse the deflected air flow over the patient's skin to change the environment around the patient.

20. A patient interface according to claim 13, wherein the deflected air flow is directed to one or more specific areas of the patient's airway as the supplemental activity.

21. A patient interface according to any one of claims 13 to 20, wherein the patient interface comprises a frame configured to conform to the shape of the patient's face, the supplemental flow device forming a part of the patient interface and arranged in the frame to direct the offset air flow as part of the supplemental activity.

22. A patient interface according to claim 19, wherein the supplemental flow device includes a path for directing the deflected air flow, the path being at least partially disposed on the frame of the patient interface.

23. A patient interface according to any one of claims 13 to 20, wherein the patient interface comprises more than one supplemental flow device for deflecting the air flow towards more than one location away from the airway of the patient.

24. A patient interface according to claim 21, wherein the more than one supplemental flow devices are capable of being used to deliver more than one active supplemental therapy and / or passive supplemental therapy to the patient, wherein the active supplemental therapy is configured to stimulate a response within the patient and wherein the passive supplemental therapy is configured to change the environment around the patient.

25. A patient interface according to any one of claims 13 to 20, wherein the supplemental flow device comprises an array of orifices configured to deflect the air flow away from the airway of the patient.

26. A patient interface according to claims 13 to 20, wherein the patient interface further comprises a flow regulator valve for regulating a second portion of the air flow to the patient, the flow regulator being configured to move between an open state allowing air flow through the flow regulator and a closed state blocking air flow through the flow regulator, wherein the state of the flow regulator valve between the open state and the closed state depends on the orientation of the patient interface.

27. A patient interface according to claim 26, wherein the flow regulator valve is arranged to move between the closed state and the open state under the action of gravity.

28. A system for delivering pressurized air or breathable gas to a patient, the system comprising: Apparatus for delivering pressurized air or breathable gas to a patient, the apparatus comprising: a flow generator configured to generate an air flow; a patient interface constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the patient interface configured to deliver the pressurized air or breathable gas to the patient's airway for respiratory therapy; an air delivery tube coupled between the flow generator and the patient interface to deliver a first portion of the flow of air from the flow generator to the patient interface as the pressurized air or breathable gas; a supplemental flow device configured to deliver a second portion of the flow of air to the patient as a supplemental activity of the respiratory therapy; and A sensory monitoring and stimulation unit and a controller configured relative to the flow generator to set the operation of the supplemental flow device.

29. A system according to claim 28, wherein the sensory monitoring and stimulation unit is connected to one or more sensors, the one or more sensors are configured to detect physiological data of the patient, and the controller is configured to set the operation of the supplemental flow device based on signals from the one or more sensors.

30. A system according to claim 28, wherein the sensory monitoring and stimulation unit is connected to one or more sensors, the one or more sensors are configured to detect data of the patient's sleeping environment, and the controller is configured to set the operation of the supplemental flow device based on signals from the one or more sensors.

31. A method for delivering pressurized air or breathable gas to a patient, comprising: arranging a patient interface to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway; generating a flow of air to be delivered to the patient interface as the pressurized air or breathable gas; delivering a first portion of the flow of air as the pressurized air or breathable gas to the airway of the patient via the patient interface for respiratory therapy; as well as A second portion of the flow of air is delivered to the patient as a supplemental activity to the respiratory therapy.

32. The method of claim 31 , wherein at least a portion of the second portion of the air flow is directed away from the airway of the patient.

33. The method of claim 32, wherein the second portion of the air flow is directed outside of the patient interface.

34. The method of claim 33, wherein the second portion of the air flow is directed onto the patient's skin.

35. The method of claim 31 , wherein the second portion of the air flow is directed to one or more specific areas of the patient's airway as the supplemental activity.

36. A method according to any one of claims 31 to 35, wherein the method uses one or more sensors configured to detect physiological data of the patient, and delivering the second portion of the air flow as a supplemental activity is at least partially based on signals from the one or more sensors.

37. A method according to any one of claims 31 to 35, wherein the method uses one or more sensors configured to detect data of the patient's sleeping environment, and delivering the second portion of the air flow as a supplemental activity is at least partially based on signals from the one or more sensors.

38. A flow regulator valve for use with an apparatus for delivering pressurized air or breathable gas to a patient for respiratory therapy, the flow regulator valve being configured to regulate air flow to the patient as a supplemental activity to the respiratory therapy, the flow regulator being configured to move between an open state allowing air flow through the flow regulator and a closed state blocking air flow through the flow regulator, wherein the state of the flow regulator valve between the open state and the closed state depends on the orientation of the apparatus.

39. The flow regulator valve of claim 38, wherein the flow regulator valve is arranged to move between the closed state and the open state under the action of gravity.

Citation Information

Patent Citations

  • Positive-Air-Pressure Machine Conduit

    US20070246043A1

  • Patient interface

    US20090044808A1

  • Mask vent

    US20090050156A1

  • Patient interface systems

    US20100000534A1

  • Nasal puff with adjustable sealing means

    US4782832A